Transcription factor EB controls metabolic flexibility during exercise by Armani, Andrea
    
      
 
 
        Sede Amministrativa: Università degli Studi di Padova 
                Dipartimento di Biologia 
 
CORSO DI DOTTORATO DI RICERCA IN: BIOSCIENZE E BIOTECNOLOGIA 
CURRICOLUM: NEUROBIOLOGIA 
CICLO XXIX 
 
 
 
 
Transcription Factor EB controls metabolic 
flexibility during exercise 
 
 
 Tesi redatta con il contributo finanziario del Fondazione CaRiPaRo  
 
 
Coordinatore: Ch.mo Prof. Paolo Bernardi 
Supervisore: Ch.mo Prof. Marco Sandri 
 
 
 
       Dottorando : Andrea Armani 
          
 
                                                                                                                                         Index 
 
Index 
 
Abstract	   I	  
Riassunto	   V	  
Publications	   IX	  
1	   Introduction	   1	  
1.1	   Skeletal	  muscle	   1	  1.1.1	   Structure	  and	  function	   1	  1.1.2	   Muscle	  fiber	  diversity	   6	  
1.2	   Skeletal	  muscle	  plasticity:	  hypertrophy	  versus	  atrophy	   7	  1.2.1	   Muscle	  hypertrophy	   8	  1.2.2	   Muscle	  atrophy	   9	  
1.3	   Protein	  and	  organelles	  breakdown	  in	  skeletal	  muscle	   11	  1.3.1	   The	  ubiquitin-­‐proteasome	  system	   11	  1.3.2	   The	  autophagy-­‐lysosome	  system	   13	  
1.4	   Transcription	  factor	  EB	   18	  1.4.1	   MiT	  family	  of	  transcription	  factors	   18	  1.4.2	   TFEB	  gene	  network	  and	  function	   21	  1.4.3	   Regulation	  of	  TFEB	  activity	   22	  1.4.4	   In	  vivo	  studies	  and	  potential	  role	  of	  TFEB	  as	  therapeutic	  target	  for	  disease	   24	  
1.5	   Exercise	  metabolism	  and	  the	  skeletal	  muscle	  adaptation	   26	  1.5.1	   Molecular	  basis	  of	  skeletal	  muscle	  adaptation	  to	  exercise	   26	  1.5.2	   Regulation	  of	  skeletal	  muscle	  gene	  expression	  during	  adaptation	   28	  1.5.3	   Modalities	  of	  exercise	   29	  1.5.4	   Metabolic	  response	  to	  an	  acute	  bout	  of	  exercise	   30	  1.5.5	   Muscle	  metabolism	  during	  the	  post-­‐exercise	  recovery	  period	   31	  1.5.6	   Activity	  dependent	  signaling	  pathways	   32	  
2	   Aim	  of	  the	  study	   37	  
3	   MATERIALS	  AND	  METHODS	   39	  
3.1	   High-­‐content	  nuclear	  translocation	  assay	   39	  
Index 
 
3.2	   Cell	  culture,	  plasmids,	  siRNA	  transfection	  and	  drugs	  tratments	   40	  
3.3	   In	  vivo	  skeletal	  muscle	  electroporation,	  plasmids	  and	  IF	   40	  
3.4	   Immunofluorescence	   41	  
3.5	   Acute	  exercise,	  mild	  exercise	  and	  training	  protocols	   41	  
3.6	   Generation	  of	  muscle-­‐specific	  TFEB	  Knockout	  and	  inducible	  muscle-­‐specific	  
transgenic	  mice	  and	  AAV	  infection	  procedures	   42	  3.6.1	   Genotyping	  of	  muscle	  specific	  TFEB	  knockout	  and	  transgenic	  mice	   43	  
3.7	   Microarray	  data	  processing	   43	  3.7.1	   Statistical	  analysis	  of	  differential	  gene	  expression	   44	  3.7.2	   Microarray	  data	  analysis	   44	  
3.8	   Electron	  microscopy	   44	  
3.9	   Biochemical	  Analysis	  of	  Mitochondrial	  Respiratory	  Chain	  Complex	   45	  
3.10	   ATP	  quantification	  in	  skeletal	  muscle	   46	  
3.11	   Isolation	  of	  skeletal	  myofibers	  and	  measurements	  of	  mitochondrial	  
membrane	  potential	   46	  
3.12	   Mitochondrial	  respiration	  assay	   47	  
3.13	   Morphological	  Analysis	   47	  
3.14	   Immunohistochemistry	   48	  
3.15	   Western	  Blot	  Analysis	  and	  Antibodies	   48	  
3.16	   Whole	  Body	  Indirect	  Calorimetry.	   49	  
3.17	   Plasma	  metabolites	  analysis.	   49	  
3.18	   Tissue	  metabolites	  quantification	   49	  
3.19	   In	  Vivo	  Assessment	  of	  Insulin	  Action	  and	  Glucose	  Metabolism	   50	  
3.20	   Autophagic	  flux	  quantification	   51	  
3.21	   In	  vivo	  ChIP	  Assays	   51	  
3.22	   Statistical	  analysis.	   52	  
3.23	   Real-­‐time	  PCR	   52	  
4	   Results	   57	  
4.1	   Calcineurin	  is	  the	  phosphatase	  driving	  TFEB	  nuclear	  translocation	   57	  
4.2	   Calcineurin	  modulates	  TFEB	  subcellular	  localization	  during	  exercise	   59	  
4.3	   Generation	  of	  muscle	  specific	  TFEB	  overexpressing	  and	  KO	  animals	   61	  
                                                                                                                                         Index 
 
4.4	   Genome-­‐wide	  analyses	  identified	  glucose-­‐related	  and	  mitochondrial	  genes	  as	  
downstream	  targets	  of	  TFEB	   62	  
4.5	   TFEB	  regulates	  mitochondrial	  biogenesis	  in	  skeletal	  muscle	   63	  
4.6	   TFEB	  regulates	  mitochondrial	  function	  and	  energy	  production	  in	  skeletal	  
muscle	   66	  
4.7	   TFEB	  regulates	  mitochondrial	  biogenesis	  in	  skeletal	  muscle	  through	  a	  PGC1α-­‐
independent	  mechanism	   68	  
4.8	   TFEB	  controls	  energy	  balance	  in	  skeletal	  muscle	  during	  exercise	   70	  
4.9	   TFEB	  controls	  metabolic	  flexibility	  and	  energy	  balance	  independently	  of	  
autophagy	  and	  proteostasis	   74	  
4.10	   TFEB	  controls	  glucose	  homeostasis	  and	  insulin	  sensitivity	  independently	  of	  
PGC1α	  75	  
4.11	   Glucose-­‐related	  signaling	  pathways	  are	  affected	  by	  TFEB	   78	  
5	   Discussion	   81	  
6	   References	   85	  
	  
 	  
Index 
 
	  
 	  
                                                                Abstract 
 
 I 
Abstract 
 
Skeletal muscle is the most abundant tissue in the whole organism representing more than 
40% of the total body mass. This organ is responsible for the 30% of metabolic rate in 
basal condition, suggesting its great relevance not only for locomotor activity, but also for 
the control of whole body metabolism. Indeed skeletal muscle is a highly dynamic tissue 
that modulates its metabolism and mass as a consequence of different physiopathological 
conditions. One stimulus that triggers major adaptations is exercise, which is also well 
known to activate autophagy (Grumati, Coletto, Schiavinato, et al., 2011). Physical 
exercise elicits several beneficial effects acting on mitochondrial content/function, fatty 
acid oxidation and glucose uptake; however it is considered a disruptive trigger for 
myofiber homeostasis that needs to be counterbalanced through the activation of 
transcriptionally regulated pathways ready to contrast mechanical and metabolic stresses 
produced during contraction. The role of FoxOs transcription factors and TFEB in 
regulating protein breakdown and autophagy is known (Milan et al., 2015; Settembre et al., 
2011). However the role of TFEB in skeletal muscle and its possible effects in controlling 
exercise-dependent adaptations in this tissue were not proved. 
 
TFEB has been proposed as the key factor that coordinates autophagy to lysosomal 
biogenesis in cell culture, with different evidences showing the regulation of its activity. In 
particular it is known that an mTORC1 phosphorylation is able to prevent TFEB function 
by retaining it in the cytoplasm. However, there were no evidences concerning the possible 
phosphatases involved in TFEB activation.  
Using a cellular high content screening able to monitor TFEB nuclear translocation during 
starvation, we identified PPP3CB, the catalytic subunit of calcineurin, as one of the highest 
hit for TFEB nuclear relocalization. We demonstrated that calcineurin activity is necessary 
and sufficient to push TFEB in the nucleus, where it can complete its function. 
Nevertheless, calcineurin is known to be active in skeletal muscle during contraction as a 
consequence of calcium oscillations. For this reason we wondered whether calcineurin 
activity could affect TFEB translocation also in adult skeletal muscle during exercise. 
Abstract 
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Using muscles transfected with a TFEB-GFP reporter, we demonstrated that calcineurin 
activity is necessary and sufficient to promote TFEB nuclear translocation even in adult 
skeletal muscle during coxntraction. 
However, the physiological meaning of this nuclear translocation in skeletal muscle 
remained to be addressed. 
To answer this question we used gain and loss of function approaches, by mean of viral 
infection of TFEB overesxpressing vectors, muscle specific TFEB knockout animals and 
tamoxifen inducible muscle specific TFEB transgenic animals. 
From microarray analysis of muscles overexpressing and lacking TFEB, we realized that 
the major pathways affected by genetic manipulation are related to mitochondrial 
biogenesis and function, lipid utilization and glucose homeostasis. Thus we started to 
dissect the function of TFEB in skeletal muscle proving that its activation is required for 
mitochondrial biogenesis that is indeed increased in transgenic muscle. We also found an 
augmented mitochondrial number and size in transgenic muscle, with only a small 
percentage of dysfunctional mitochondria in KO animals. 
These changes were paralleled by a TFEB signature in gene expression of genes involved 
in mitochondrial biogenesis and functionality. Moreover, these morphometric and gene 
expression evidences correlate with increased mitochondrial respiration and higher activity 
of respiratory chain complexes. For this reason transgenic muscles produce more ATP than 
normal mice, while KO muscles have a lower ATP synthesis because mitochondria present 
a leak in mitochondrial membrane that dissipate membrane potential. 
Nevertheless, in order to understand if TFEB is able to promote this mitochondrial 
program independently from PGC1α, we checked the expression of NRF1/2, TFAM and 
other genes involved in mitochondrial biogenesis in a model of PGC1α ablation during 
TFEB overexpression. These data, and complexes activity measurements, demonstrate that 
TFEB is able per se to activate the transcriptional program directly binding to NRF1 and 
NRF2 genes promoters without the need of the transcriptional co-activator. 
At this point, we challenged mice with exercise finding that transgenic mice are more 
resistant to exhaustive contraction than control; conversely muscle specific TFEB-KO 
animals display pronounced exercise intolerance due to their lack in ATP production. 
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In order to better explain this latter finding, thanks to metabolic measurements we realized 
that KO muscles rely more on glucose oxidation both in basal condition and during the 
first phases of exercise thus explaining the observed exercise intolerance triggered by 
glycogen storage depletion. Furthermore lactate quantification in serum before and after 
exercise suggests that KO animal depend more on anaerobic glycolysis with respect to 
control and transgenic counterpart. To deeply investigate the role of glucose oxidation that 
seems the cause of exercise intolerance, we monitored glycogen levels in muscle of KO 
animals in resting condition, revealing a reduction of glycogen storage. For this reason 
after the early stages of exercise TFEB-KO animals need to rapidly shift their metabolism 
to fatty acid oxidation that however cannot support energy demand because of the presence 
of dysfunctional mitochondria. 
Altogether these findings indicate that TFEB is impinging more on metabolism rather than 
autophagy, that indeed is not affected by TFEB genetic modulation; more in detail TFEB 
seems to significantly modulate muscular glucose homeostasis that is altered in KO 
animals. Reduced glucose uptake and glycogen synthesis during EU clamps explains why 
glycogen storages are depleted in KO animals, while the transgenic counterpart present 
more glycogen accumulation. This phenotypic effect is paralleled by a change in glucose 
related genes expression, with higher levels of glucose transporters and glycogen synthesis 
regulator in transgenic muscles, even in the absence of PGC1α. Nevertheless TFEB 
overexpression is also able to drive factors such as nNOS and AMPK activity, thus 
modulating not only the expression but also the signalling pathways related to glucose 
homeostasis.  
In conclusion all these findings strongly support a new vision of TFEB as master regulator 
of metabolic flexibility during physical exercise in a PGC1α-independent fashion.  
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 V 
Riassunto 
 
Il muscolo scheletrico è il tessuto più abbondante dell’organismo e rappresenta più del 
40% della massa corporea. Questo organo è responsabile del 30% della spesa energetica a 
riposo, suggerendo la sua importanza non solo a livello di locomozione ma anche nel 
controllo del metabolismo a livello sistemico. Infatti il muscolo scheletrico è un tessuto 
estremamente dinamico, capace di modulare il suo metabolismo in seguito a stimoli di 
diversa natura. Uno stimolo che attiva maggiori adattamenti metabolici è l’esercizio, che è 
noto attivare anche l’autofagia. 
L’esercizio fisico stimola molti effetti benefici sul contenuto e funzionalità mitocondriale, 
ossidazione degli acidi grassi e assorbimento del glucosio; tuttavia, è considerato uno 
stimolo che danneggia la normale omeostasi delle fibre muscolari per cui necessita di 
essere controbilanciato dall’attivazione di meccanismi trascrizionalmente controllati che 
contrastano gli stress meccanici e metabolici prodotti durante la contrazione. Il ruolo dei 
fattori di trascrizione FoxO e TFEB nel regolare la degradazione proteica e l’autofagia è 
largamente conosciuto. Tuttavia, il ruolo di TFEB nel muscolo scheletrico e i suoi possibili 
effetti nel regolare gli adattamenti derivanti dall’esercizio in questo tessuto non sono 
ancora chiari.  
 
TFEB è stato proposto come fattore chiave nel coordinare autofagia e biogenesi 
lisosomiale in cellule in coltura, con diverse evidenze che dimostrano la regolazione della 
sua attività. In particolare è noto come la fosforilazione operata da mTORC1 sia in grado 
di prevenire l’attivazione di TFEB sequestrandolo nel citoplasma. Tuttavia, non esistono 
dati riguardanti le possibili fosfatasi coinvolte nell’attivazione di TFEB. 
Mediante l’utilizzo di uno High Content Screening in grado di monitorare la traslocazione 
di TFEB nel nucleo durante la starvation, abbiamo identificato il gene PPP3CB,  
codificante la subunità catalitica della calcineurina, come uno dei migliori geni coinvolti 
nella rilocalizzazione di TFEB. Abbiamo dimostrato che l’attività della calcineurina è 
necessaria e sufficiente per spingere TFEB nel nucleo, dove può espletare la sua funzione. 
Tuttavia, la calcineurina è noto essere attiva nel muscolo scheletrico durante la contrazione 
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come conseguenza dei transienti di calcio. Per questo motivo ci siamo chiesti se l’attività 
della calcineurina possa influenzare la traslocazione di TFEB nel nucleo anche nel 
muscolo scheletrico durante l’esercizio fisico. Utilizzando un reporter TFEB-GFP abbiamo 
dimostrato che l’attività della calcineurina è necessaria e sufficiente a promuovere la 
traslocazione nucleare di TFEB anche nel muscolo scheletrico durante la contrazione. 
Tuttavia il significato fisiologico di questo avvenimento rimane da essere spiegato. 
Per rispondere a questa domanda abbiamo usato degli approcci di gain e loss of function 
utilizzando infezioni virali con vettori per l’overespressione di TFEB, una linea di topi con 
delezione muscolo specifica di TFEB e un’altra linea in cui l’overespressione di TFEB può 
essere attivata in muscolo grazie al tamoxifen. 
Da uno studio di espressione genica in muscoli overesprimenti TFEB e TFEB deficienti, 
abbiamo trovato che le vie di segnale principalmente coinvolte dalle manipolazioni 
genetiche erano quelle correlate alla biogenesi mitocondriale, utilizzo dei lipidi e 
omeostasi del glucosio. Abbiamo perciò cominciato a dissezionare il ruolo di TFEB nel 
muscolo scheletrico provando che la sua attivazione è richiesta per la biogenesi 
mitocondriale, che è per l'appunto aumentata nei muscoli transgenici. Infatti, in questi 
abbiamo trovato un aumento nel numero e nella dimensione dei mitocondri, mentre 
abbiamo riportato solo una piccola percentuale di mitocondri disfunzionali nei muscoli 
knockout. 
Questi cambiamenti sono accompagnati da un’attivazione dei geni TFEB-dipendenti 
responsabili per la biogenesi e funzionalità mitocondriale. Inoltre, questi cambiamenti 
morfometrici e di espressione genica correlano con un aumento nella respirazione 
mitocondriale e nell’attività dei complessi della catena respiratoria. Per questo motivo i 
muscoli transgenici producono più ATP dei wildtype, mentre i muscoli KO presentano una 
ridotta sintesi di ATP a causa di una disfunzionalità della membrana mitocondriale che 
dissipa il gradiente protonico. Tuttavia, per capire se questi cambiamenti dipendono 
direttamente da TFEB indipendentemente da PGC1α, abbiamo monitorato l’espressione di 
NRF1/2, TFAM e altri geni coinvolti nella biogenesi mitocondriale in un modello in cui 
PGC1α è deleto e TFEB overespresso. Questi dati di espressione uniti alle misure delle 
attività dei complessi dimostrano che TFEB è in grado di indurre autonomamente la 
biogenesi mitocondriale legandosi direttamente ai promotori dei geni NRF1 e NRF2. 
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A questo punto abbiamo sottoposto a esercizio i topi riscontrando che gli animali 
transgenici resistono maggiormente all’attività fisica; al contrario i topi KO presentano una 
marcata intolleranza all’esercizio a causa della scarsa produzione di ATP. Per spiegare 
meglio questo fenomeno, grazie a misurazioni di parametri metabolici abbiamo riscontrato 
che i topi KO fanno affidamento maggiormente nell’ossidazione del glucosio sia a riposo 
che durante le fasi iniziali dell’esercizio fisico, spiegando l’intolleranza con la fine delle 
riserve di glicogeno. Inoltre, le quantificazioni del lattato nel siero prima e dopo l’esercizio 
suggeriscono che i muscoli KO dipendono maggiormente dalla glicolisi anaerobia a 
differenza delle controparti wildtype e transgenica. A questo punto, per investigare più in 
dettaglio il ruolo dell’ossidazione del glucosio che sembra essere alla base dell’intolleranza 
all’esercizio, abbiamo misurato i livelli di glucosio intramuscolare negli animali KO, 
notando che a riposo questi presentano una riduzione considerevole delle riserve. Per 
questo motivo gli animali KO, dopo i primi momenti di esercizio, sono costretti a cambiare 
il loro metabolismo verso una maggiore ossidazione degli acidi grassi che comunque non 
riesce a supportare la domanda energetica a causa dei mitocondri disfunzionali.  
Tutte queste evidenze indicano che TFEB controlla più il metabolismo rispetto 
all’autofagia la quale non è influenzata dalla modulazione genetica di TFEB; più in 
dettaglio TFEB sembra controllare direttamente il metabolismo del glucosio che è alterato 
negli animali TFEB-deficienti. Un ridotto assorbimento del glucosio e una ridotta sintesi 
del glicogeno durante gli EU-clamps spiegano perché le riserve di glicogeno sono ridotte 
negli animali KO mentre la controparte transgenica ne accumula in più. Questi effetti 
fenotipici sono accompagnati da un cambiamento nell’espressione di geni connessi 
all’omeostasi del glucosio, con maggiore presenza di trascritti per i trasportatori di 
glucosio and regolatori della sintesi del glicogeno nei muscoli transgenici, anche in assenza 
di PGC1α. Inoltre, l’overespressione di TFEB è in grado di modulare anche l’attività di 
nNOS e AMPK, influenzando l’omeostasi del glucosio non solo dal punto di visto 
trascrizionale, ma impattando anche sulle vie di segnale ad esso correlate. 
In conclusione tutte queste scoperte sostengono fortemente una nuova visione di TFEB 
come un fattore chiave nella regolazione della flessibilità metabolica durante l’esercizio 
fisico in modo indipendente da PGC1α. 
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 1 
1 Introduction 
 
1.1 Skeletal muscle 
Skeletal muscle is the most abundant tissue in the whole organism representing almost 
40% of the body weight and, due to its predominant protein component, can be considered 
the major protein reservoir of the organism (Bonaldo & Sandri, 2013).  
It is primarily know for its control of body posture and movement; nevertheless it has been 
demonstrated since early 80s its important role in the control of blood glycemia and 
metabolic homeostasis (DeFronzo, Ferrannini, Sato, Felig, & Wahren, 1981; DeFronzo, 
Jacot, et al., 1981). 
Starting from these evidences, researchers focused their attention on this organ not only for 
its contractile properties but also for its pivotal role in controlling whole body metabolism. 
 
1.1.1 Structure and function 
Skeletal muscle is a highly complex organ, made up of specialized contractile cells called 
myofibers. Nonetheless, this organ needs the contribution of other tissues in order to 
maintain its homeostasis and guarantee its proper functionality.  
That is the case of connective tissue that provides a robust extra-cellular matrix (ECM) 
able to determine a specialized organization of muscle fibers.  ECM can be found not only 
surrounding myofibers (endomysium); indeed connective tissue is also able to create an 
envelope (perimysium) that groups fibers in fascicles. Furthermore, an additional layer of 
ECM, the epimysium, glues together all fascicles in order to form the final entire muscle. 
Skeletal muscles are also connected to bones through tendons, specialized structures 
mainly composed by ECM proteins which couple muscle contraction to movement 
generation (Figure 1). 
However, connective tissue is not the only tissue required; blood vessels and nerves are 
also principal components that can be found inside a muscle, positioned in the ECM 
forming the endomysium. Blood vessels are fundamental to support and ensure metabolites 
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exchanges; moreover, nerve terminals from motor-neurons are contacting myofibers in 
specialized synapses called neuromuscular junctions (NMJs) in order to provide the 
stimulus required for contraction.  
 
 
From a histological point of view, skeletal muscle is a complex post-mitotic tissue formed 
by a tight organisation of myofibers, long cylindrical multinucleated cells.  
Due to their particular specialization in contraction, muscle cells present an extremely 
reduced cytosol with all the space occupied by thousand of myofibrils composed by long 
series of sarcomeres, the contractile units of the cell. A sarcomere is a huge protein 
complex composed by regularly alterned actin and myosin filaments, kept in the correct 
position by several important structural and regulatory proteins such as troponin, 
tropomyosin, titin and desmin. 
Sarcomeres were described for the first time thanks to microscopy techniques that 
highlighted the presence of isotropic (light band) and anisotropic (dark band) zones, 
forming the specific striated aspect of skeletal muscle.  
Figure 1 - Schematic representation of skeletal muscle structure  
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Later electron microscope analysis led to the identification of a precise structural pattern in 
which two electrondense lines observed across the extremities (Z-lines) define the 
sarcomeric unit. Moreover from these studies, a light band (I-band) and a dark band (A-
band) can be observed. Each I-band spans between to adjacent sarcomeres, including the 
Z-line in its middle; in addition, within the A-band, a paler region called the H-band 
presents in the middle a thin M-line, the middle-line of the sarcomere.  
 
 
These bands are not only morphological features but also functional units since they are 
characterized by the presence of different contractile proteins. Actin filaments (thin 
filaments) are the major components of the I-band and extend into the A band where the 
overlapping with myosin filaments gives rise to the known shift in light conductance. 
Thick filaments extend throughout the entire A-band and are thought to overlap in middle 
of the sarcomere where they give rise to M-band. Another structural protein, called titin, 
extends from the Z-line of the sarcomere, where it binds the thin filament system, to the 
M-band, where it is thought to interact with the thick filaments. Several proteins important 
for the stability of the sarcomeric structure are found in the Z-line as well as in the M band 
of the sarcomere (Figure 2). Actin filaments and titin molecules are cross-linked in the Z-
disc via the Z-line protein alpha-actinin. The M-band myosins together with the M proteins 
bridge the thick filament system to the M-band part of titin (the elastic filaments). 
Figure 2 - Scheme of sarcomere organization 
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Moreover several regulatory proteins, such as tropomyosin and troponin bind myosin 
molecules, modulating their contraction properties. 
 
Contraction is the typical feature of muscle fibers, which are able to convert chemical 
energy into mechanical force generation. In 1954, scientists published two groundbreaking 
papers describing the molecular basis of muscle contraction. These works described the 
position of myosin and actin filaments at various stages of contraction in muscle fibers and 
proposed how this interaction, now known as “cross-bridge”, produced contractile force. 
Using high-resolution microscopy, A. F. Huxley and R. Niedergerke (A. F. Huxley & 
Niedergerke, 1954) and H. E. Huxley and J. Hanson (H. Huxley & Hanson, 1954) 
observed changes in the sarcomeres as muscle tissue shortened. They noticed that the A-
band remained relatively constant in length during contraction suggesting that the myosin 
filaments remained central and constant in length while other regions of the sarcomere 
shortened. The investigators also observed that the I-band changed its length along with 
the sarcomere and H-band disappears. These observations led them to propose the sliding 
filament theory, which states that the sliding of actin on myosin is the source muscle 
tension. Thus, since actin is tethered to Z-lines, any shortening of the actin filament length 
would result in a shortening of the entire sarcomere with the two Z-lines defining at the 
boundaries getting closer one to the other. 
Muscle contraction is determined by a mechanism called excitation-contraction coupling. 
Excitation is coming from a motor neuron that is contacting myofibers at the neuro-
muscular junction; action potential is traveling from the neuron to the plasma membrane 
(sarcolemma) of the post-sinaptic cell (muscle cell) where the induced depolarization 
triggers a series of intracellular events leading to muscle contraction. Sarcolemma 
depolarization results in an increase in cytosolic calcium, the so-called calcium transient, 
which activates calcium-sensitive contractile proteins and allows myosin head to contact 
thin filaments and pull them towards M-line thanks to ATP hydrolysis. In this way, the 
electrical stimulus is converted in a signal cascade that brings chemical energy to be 
transformed in mechanical force. 
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The coordination of contraction in all the sarcomeres present in a myofiber makes it 
possible to modify the length of the whole muscle cell and as consequence of the entire 
muscle.  
 
 
To allow the simultaneous contraction of all sarcomeres, muscle fibers display a particular 
structure in which the sarcolemma penetrates into the cytoplasm between myofibrils, 
forming membranous tubules running parallel to the Z-line, the transverse tubules (T-
tubules)  (Figure 3). Thanks to the Ryanodine Receptor complex (RyR1), T-tubules are 
electrically coupled with the terminal cisternae, particular expansions of the sarcoplasmic 
reticulum (SR) that extend from both sides of T-tubules into the myofibrils. SR is the 
enlargement of smooth Endoplasmic Reticulum (ER) and contains the majority of calcium 
ions required for contraction. Anatomically, the structure formed by T-tubules surrounded 
by two smooth ER cisternae is called triad and it allows the transmission of membrane 
depolarization from the sarcolemma to the ER. The contraction starts when an action 
potential diffuses from the motor neuron to the sarcolemma and then it travels along T-
tubules until it reaches the sarcoplasmic reticulum. Here the action potential, through the 
release of acetylcholine (ACh) from the synaptic terminal, induces changes in the 
permeability of the sarcoplasmic reticulum, allowing the flow of calcium ions into the 
cytosol between myofibrils. Here, the release of calcium ions induces the myosin heads to 
Figure 3 - T-tubuls and triad organization in a skeletal muscle fiber 
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interact with the actin, allowing muscle contraction, an ATP dependent process. Energy in 
skeletal muscle is provided by mitochondria, which, due to the particular spatial 
organisation, are located closed to Z-lines. 
 
1.1.2 Muscle fiber diversity 
Contractile properties of skeletal muscle depend principally on their fiber type 
composition. Indeed mammalian muscle fibers are divided in two distinct classes: type I, 
also called slow-twitch fibers, and type II, referred as fast-twitch fibers. This classification, 
based on the speed of tension development and relaxation, also coincides with 
histochemical staining for myosin ATPase activity, which is higher in fast-type II fibers. 
This classification mainly considers the mechanical properties of different fiber types; 
however, since early studies, muscles have been also classified as red and white, 
depending on their fresh appearance. This difference in color reflects both the amount of 
blood perfusion as well as the abundance of the oxygen transport protein myoglobin, 
which is closely related to mitochondrial density and the relative contribution of oxidative 
metabolism in the different fiber types. 
At this point it is clear that besides mechanical properties different fiber types also display 
peculiar metabolic features, mitochondrial contents and resistance to fatigue (Pette & 
Heilmann, 1979; Schiaffino, Sandri, & Murgia, 2007).  
 
Each muscle is composed by a combination of fiber types, whose abundance affects not 
only the type of contraction the muscle undergoes (fast or slow) but metabolism and 
physiology of the specific organ. 
Different fiber types are also characterized by peculiar Myosin Heavy Chain (MHC) 
protein expression. Type I fibers express the slow isoform of MHC (MHCβ or MHC1), 
and present a great mitochondrial content, high levels of myoglobin, high capillary 
densities and high oxidative capacity. Conversely, type II fast fibers are divided in three 
different groups depending on which myosin isotype is expressed; indeed distinct genes 
encode for MHC IIa, IIx (also called IId) and IIb. Type IIa myofibers are faster than type I, 
but they are still relatively fatigue-resistant. IIa fibers are relatively slower than IIx and IIb 
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and have an oxidative metabolism due to the rich content of mitochondria (Schiaffino & 
Reggiani, 1996, 2011). Given all these characteristics, IIa fibers are also termed fast 
oxidative because they exhibit fast contraction, high oxidative capacity and a relative 
fatigue resistance. By the other hand, type IIx and IIb fibers are known as fast-glycolitic 
showing a prominent glycolitic metabolism, poor mitochondrial content, high myosin 
ATPase activity; all these features, coupled with the expression of MHC IIb and MHC IIx 
proteins, determine the fastest rate of contraction and the highest level of fatigability.  
The fiber-type profile of different muscles is initially established during development 
independently of neural influences even if nerve activity has a major role in the 
maintenance and modulation of fiber properties in adulthood. During postnatal 
development and regeneration, a default nerve activity-independent pathway of muscle 
fiber differentiation leads to the activation of the fast gene program. On the contrary, post-
natal induction and maintenance of the slow gene program is dependent on slow motor-
neuron activity. Thus, nerves have an impact on fiber type determination and modulation 
of nerve activity can result in a switch of fiber type in adult skeletal muscles (Murgia et al., 
2000). 
At this point it is clear that the transcription of different fiber type-specific genes must be 
precisely coordinated in skeletal muscle fibers to maintain muscle function; for this reason 
different signaling pathways control muscle fiber type specific gene programs. Moreover 
fiber type transformations involve changes in all muscle cell compartments, including 
components of the excitation-contraction coupling, cell metabolism, and contractile 
machinery. Thus, fiber type composition is generally determined during development, but 
the possible adaptive “transformation” of muscle fibers from one type to another is still 
hotly debated (Booth, Laye, & Spangenburg, 2010). 
 
1.2 Skeletal muscle plasticity: hypertrophy versus atrophy 
Skeletal muscle is an extremely plastic tissue, able to adapt to a broad variety of stimuli 
including to only nutritional status, but also mechanical overload, nerve activity, exercise 
and stimulation by growth factors and hormones (Mounier, Theret, Lantier, Foretz, & 
Viollet, 2015). 
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Muscle mass is indeed highly dynamic and muscle fiber size can vary according to 
physiological and pathological conditions. In any case, muscle size is the outcome of a 
balance between protein synthesis and protein degradation (Figure 4). Thus, muscle growth 
is determined by excessive synthesis that leads to muscle hypertrophy; on the other hand, 
excessive protein degradation, loss of organelles and cytoplasm are the major causes of 
muscle atrophy.  
 
 
 
1.2.1 Muscle hypertrophy 
In response to physical activity, or upon hormones stimulation, muscle mass is increased 
mainly as a result of prompted biosynthesis and decreased degradation of its protein 
constituents (McCarthy & Esser, 2007). The outcome of this anabolic state is named 
muscle hypertrophy, and is paralleled by an increase in the force developed by the muscle 
during contraction (Velloso, 2008). The IGF1-AKT signaling is the major pathway 
controlling muscle growth. IGF1 can be produced either by liver under growth hormone 
Figure 4 - Schematic view of the main pathways controlling muscle mass (Bonaldo & Sandri, 
2013) 
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(GH) control, or locally by skeletal muscle itself. Specific isoforms that drive load- and 
stretch-induced adaptations in skeletal muscle have been discovered and characterized. 
Binding of IGF1 to its receptor starts a signal cascade that culminates in the activation of 
AKT by phosphorylation. Active AKT inhibits protein degradation by phosphorylating and 
thus repressing the transcription factors of the FoxO family; in parallel, it stimulates 
protein synthesis via mammalian target of rapamycin (mTOR) activation and glycogen 
synthase kinase 3β (GSK3β) inhibition (Schiaffino & Mammucari, 2011). Active mTOR, a 
well-known regulator of cell growth, promotes the activation of S6 kinase (S6K) and 
blocks 4EB-P1, the eukaryotic translation factor 4E (eif4e) inhibitor; also AKT-driven 
inhibition of GSK3β stimulates proteins synthesis, preventing GSK3β inhibitory action on 
protein translation promoted by eIF2B (Glass, 2005). To better clarify the role of AKT in 
skeletal muscle hypertrophy, a conditional transgenic mouse was produced in which 
constitutively active form of AKT in expressed in skeletal muscle only after tamoxifen 
treatment. Upon activation of the transgene, these mice undergo a significant increase in 
muscle mass mainly due to newly synthesized proteins (Blaauw et al., 2009), providing 
strong evidence supporting the idea that AKT activation is sufficient to induce skeletal 
muscle growth and that IGF1-AKT axis is the major mediator of muscle hypertrophy. 
Nevertheless, recent findings reported that also TGF-β and BMP pathways contribute to 
the regulation of muscle mass in adulthood (Sartori et al., 2009; Sartori et al., 2013).  
In conclusion, different pathways are now emerging, trying to clarify all the signal 
cascades involved in the control of muscle hypertrophy.  
1.2.2 Muscle atrophy 
Differently from hypertrophy, muscle atrophy is instead a decrease in myofiber size mainly 
determined by loss of organelles, cytoplasm and proteins. This process is physiologically 
induced during aging or it is due to muscle disuse, but is also important in many 
pathological conditions accompanied by muscle wasting such as cancer, diabetes, heart and 
renal failure (Lecker et al., 2006; Sandri, 2016). In 1969, Alfred Goldberg demonstrated 
that an increase in protein degradation contributed to the loss of muscle mass and 
myofibrillar proteins following denervation and glucocorticoid treatment (Goldberg, 
1969). In most muscle atrophy models overall rates of protein synthesis are suppressed and 
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rates of protein degradation are consistently elevated, determining in turn the observed 
rapid loss of muscular proteins (Bonaldo & Sandri, 2013). This is paralleled by a reduction 
in the activity of the AKT pathway representing a permissive condition for the activation 
of FoxOs transcription factors. When active AKT levels are reduced, FoxOs are 
dephosphorylated and therefore able to translocate to the nucleus, where they can drive the 
expression of several atrophy-related genes. FoxO3 is the member of the family that firstly 
has been identified to promote the expression of two fundamental muscle specific 
ubitiquitin-ligases, Atrogin-1 and MuRF-1 (Bodine et al., 2001; Gomes, Lecker, Jagoe, 
Navon, & Goldberg, 2001; Sandri et al., 2004). Moreover FoxO3 has also been 
demonstrated to be necessary and sufficient for the induction of autophagy in adult skeletal 
muscle (Mammucari et al., 2007; Zhao et al., 2007). 
In all the catabolic states, the loss of muscle mass involves a common pattern of 
transcriptional changes that includes the induction of genes for protein degradation, 
autophagy regulation and a decrease in expression of various genes involved in different 
cellular processes like energy production and growth. This group of coordinately regulated 
genes has been identified, and all the genes belonging to the atrophic program are now 
called “atrogenes”(Lecker et al., 2006). 
These genes encode for proteins involved in different cellular processes like energy 
production, transcription factors, regulators of protein synthesis and enzymes belonging to 
different metabolic pathways. Recent findings shed new light in the role of the FoxOs 
family members in the regulation of all these “atrogenes”, contributing to highlighting the 
FoxOs signature in muscle atrophy (Milan et al., 2015). 
Nevertheless, another family of transcription factors able to upregulate the expression of a 
reduced subset of atrogenes un skeletal muscle is NF-κB. It was shown that NF-κB 
signaling pathway can mediate the effects of inflammatory cytokines, in particular TNF-α 
during muscle wasting and cancer cachexia (Bonaldo & Sandri, 2013; Sandri, 2016). 
In any case, these and likely other not yet identified signaling pathways contribute to 
muscle atrophy by influencing the activity of the main degradative machineries of the cell: 
the ubiquitin-proteasome and the autophagy-lysosome systems. 
 
                                                         Introduction 
 
 11 
1.3 Protein and organelles breakdown in skeletal muscle 
Degradation of unnecessary or damaged components in eukaryotic cells involves the 
ubiquitin-proteasome (UPS) or the autophagic-lysosomal (ALS) systems (Lilienbaum, 
2013). The coordinated function of these two pathways is critical to maintain the delicate 
balance between anabolism and catabolism in cells; therefore a huge number of signaling 
pathways are involved in this fine regulation. In multicellular organisms these machineries 
are also essential to modulate the activity of hormones, to fight against pathogenic 
microorganisms, to recycle nutrients during starvation, to eliminate unnecessary structures 
and organelles during cell differentiation and to renew tissue components preventing and 
delaying aging (Mizushima & Levine, 2010). In skeletal muscle, protein breakdown occurs 
not only following disuse- or pathology-induced atrophy, but it is also necessary to 
remodel the tissue during development, to cope with nutrient depletion stress, or to remove 
damaged component (Schiaffino, Dyar, Ciciliot, Blaauw, & Sandri, 2013). A proper 
removal of damaged or unnecessary cellular components is thus essential to avoid 
accumulation of this material aggregates harmful for muscle function (Bonaldo & Sandri, 
2013). This phenomenon is particularly relevant after exercise sessions; indeed during and 
after contraction UPS and autophagy are activated to allow the clearance of contractile 
proteins and mitochondria that become damaged as a consequence of energetic, oxidative 
and mechanical stresses produced during contraction (Vainshtein & Hood, 2016). 
1.3.1 The ubiquitin-proteasome system 
Ubiquitin-proteasome system (UPS) is primarily involved in the degradation of 
intracellular short-lived proteins, but it is also associated with different regulatory 
functions. A conjugation system composed of three enzymes, E1, E2, E3 activates and 
subsequently binds chains or single molecules of ubiquitin, an 8.5 kDa regulatory protein 
that target proteins and commit them to degradation (Figure 5). The reaction is highly 
specific and broad range of E3 ligases, differentially expressed and activated in several 
conditions in the cell, determine the substrate specificity of the conjugation reaction 
(Gomes et al., 2001). Chains of ubiquitin molecules are generated through isopeptide 
bonds formed between the C-terminus of one ubiquitin molecule and a specific lysine 
residue in the next. Ubiquitin has seven Lys residues, which are all used for 
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polymerization, but polyubiquitin chains formed via Lys at 48 or 63 are the best 
characterized. A polyubiquitin chain formed via Lys48 functions mainly as a marker for 
proteolysis; in contrast, Lys63-linked polyubiuqitinated proteins are involved in membrane 
trafficking processes (Tenno et al., 2004). 
 
Proteins that need to be degraded, following the proper ubiquitination reaction, are 
addressed and recognized by the 26S proteasome, an ATP-dependent multienzyme 
complex with proteolytic activity. Through this system the normal turnover of intracellular 
proteins is maintained, and damaged or not properly folded proteins are degraded. The 
products of this degradation process are small peptides and free amino acids that can be 
reused for de novo biosynthesis or energy production (Hershko & Ciechanover, 1998). 
The ubiquitin-proteasome system is constitutively active in skeletal muscle in order to 
sustain protein turnover and guarantee correct homeostasis; nevertheless, UPS is 
Figure 5 - Schematin view of the Ubiquitin Proteasome system for protein degradation (Lecker, Goldberg, & 
Mitch, 2006) 
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responsible for the breakdown of most soluble and myofibrillar proteins during atrophy 
(Lecker et al., 2006). Indeed, the decrease in muscle mass in catabolic conditions is 
associated with: (a) increased muscular polyubiquitinated proteins; (b) increased 
proteasomal ATP-dependent activity; (c) increased protein breakdown that can be 
efficiently blocked by proteasome inhibitors; (4) upregulation of transcripts encoding 
ubiquitin, ubiquitin-conjugating enzymes (E2), ubiquitin-protein ligases (E3) and several 
proteasome subunits. Among the atrogenes, two E3 ubiquitin ligases, Fbxo32 ( also known 
as Atrogin-1) and TRIM63 (also referred as Muscle Ring Finger 1, MuRF-1) (Bodine et 
al., 2001; Gomes et al., 2001), are the most upregulated genes in different models of 
muscle atrophy, being responsible for the increased protein breakdown. These two 
enzymes have a muscle specific gene expression pattern and are activated by FoxO3; for 
this reason they can be considered the main effectors of the signaling pathways activating 
the atrophic program. 
However, since two ubiquitin ligases cannot account for the degradation of all sarcomeric 
and soluble proteins, additional E3s are for sure involved in muscle loss; recent studies 
highlighted new E3 ligases under FoxOs control whose activity is impinging in muscle 
mass loss during fasting or denervation (Milan et al., 2015; Sartori et al., 2013). For this 
reason, identification and characterization of E3 enzymes, together with their respective 
substrates, might be an important step to understand the mechanisms that control muscle 
mass loss and, thus, the first step to identify molecular targets for pharmacological 
intervention in muscle diseases.	  	  
1.3.2 The autophagy-lysosome system 
The role of the lysosome system is to degrade large intra- or extracellular structures, such 
as huge protein complexes, organelles and pathogens. Extracellular material is degraded by 
lysosomes in a process called endocytosis in which substrates are engulfed by portions of 
the plasma membrane forming the so-called endocytic vesicles that are suddenly fused 
with lysosomes. Lysosomes are hydrolytic enzyme-containing organelles specialized in the 
digestion of endocytosed material and in the release of constituents to the cytosol (Pryor & 
Luzio, 2009). When lysosomes contribute to the breakdown of material of intracellular 
origin, the process is instead named autophagy (from the greek αυτοζ “self” and ϕαγειν 
Introduction 
 14 
“eating”) (Glick, Barth, & Macleod, 2010; van Meel & Klumperman, 2008). Autophagy is 
an evolutionarily conserved process that is typically induced under nutrient poor conditions 
to ensure cellular homeostasis thanks to protein aggregates and organelles degradation 
providing in this way metabolites necessary to support biosynthesis and metabolic 
processes.  
Different types of lysosome-mediated self-digestion can be distinguished (Figure 6). In 
microautophagy the target of the digestion is a small portion of the cytosol that is directly 
engulfed by the lysosome without intervention of other vesicles (Mijaljica, Prescott, & 
Devenish, 2011). Although it is still unknown whether microautophagy occurs in skeletal 
muscle, some findings indicate that microautophagy can participate in glycogen uptake 
into lysosomes (Takikita et al., 2010).  
 
 
The chaperone protein Hsc70 (Heat shock protein cognate 70) mediates instead a different 
kind of lysosomal self-digestion called Chaperone-Mediated-Autophagy (CMA). When 
this chaperone recognizes a specific aminoacidic sequence (KFERQ) exposed on the 
surface of a misfolded protein, it is able to help protein translocation directly into 
lysosomal lumen where degradation takes place (Bejarano & Cuervo, 2010). CMA has 
Figure 6 -  Scheme of the different type of autophagy: a. maroautophagy, b. 
chaperone mediated autophagy and c. microautophagy (Cuervo, 2011) 
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raised interest owing to its potential role in aging, neurodegenerative disorders and 
lysosomal storage diseases (Kon & Cuervo, 2010); however, whether it has a role in 
skeletal muscle homeostasis is still largely unknown.  
So far, most data on the role of autophagy in muscle are related to macroautophagy, the 
process that allows the degradation of superfluous or damaged organelles and 
supramolecular complexes. 
Macroautophagy, hereafter referred to as autophagy, has been first studied in the model 
system Saccharomyces cerevisiae, leading to the identification of more than thirty genes 
involved in this process (Inoue & Klionsky, 2010). The importance of this process is now 
worldwide accepted leading to Yoshinori Ohsumi the Nobel Prize in Medicine in 2016 for 
his discoveries related to autophagy. 
For most of the autophagy-related genes (ATG genes), mammalian counterparts have been 
subsequently identified, thus demonstrating that this mechanism is highly conserved during 
evolution (Abounit, Scarabelli, & McCauley, 2012). In this process, cytoplasmic 
components including protein aggregates and organelles are engulfed by double-membrane 
structures known as autophagosomes, which fuse with lysosomes to deliver their cargo for 
degradation. Generation of different mouse reporter lines for autophagic markers showed 
that a basal autophagy rate is present in all tissues, even if stress conditions, such as 
nutrient deprivation, oxidative stress and hypoxic conditions can activate autophagy at 
different levels in a tissue specific manner. 
Thus, as for all degradative pathways, autophagy regulation is essential to specifically 
“switch on” the process for the limited time it is required. In different stress conditions, 
different signaling pathways are activated, most of them converging on the kinase mTOR, 
which plays a central role in the integration of cellular inputs and autophagy regulation 
(Tooze & Yoshimori, 2010). During nutrient deprivation or under genotoxic stress 
conditions, AMPK and p53 signaling pathways are activated thus inhibiting mTOR. 
Conversely, AKT and MAPK signaling is active under anabolic conditions or in response 
to extracellular signals respectively, leading to mTOR activation. One of the target of 
active mTOR kinase is ULK1, a crucial protein for autophagy initiation. Phosphorylation 
by mTOR inactivates ULK1, while its active form is able to assemble with other ATG 
proteins (ATG13, FIP200, ATG101 and others) in a complex that localizes at specialized 
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sites initiating the formation of a double membrane structure called isolation membrane or 
phagophore. Phagophore is the autophagosome precursor and its formation requires the 
class III phosphoinositide 3-kinase (PI3K) Vps34, which acts in a large macromolecular 
complex containing BECLIN1, ATG14, FIP200 and Vps15 (p150). The elongation of the 
autophagosomal membranes is a critical step that is associated with two ubiquitination-like 
reactions. In the first one, ATG7 and ATG10, an E1 and E2-like enzymes respectively, 
conjugate ATG12 to ATG5. The ATG5-ATG12 conjugates then interact non-covalently 
with Atg16L1 to form a large complex that facilitate the action of the LC3 conjugation 
system. The whole complex associates with growing phagophores but dissociates once the 
autophagosome formation is complete (and so the membrane is closed). In this phase, 
membranes are recruited especially form ER and mitochondria (Tooze & Yoshimori, 
2010). In the second ubiquitin-like reaction, microtubule-associated protein 1 light chain 3 
or LC3 (MAP1LC3, the mammalian homolog of yeast Atg8), after a proteolytic cleavage 
by ATG4 that generate the cytosolic form of the protein (LC3-I), is then conjugated to the 
lipid phosphatidylethanolamine (PE) with a covalent bond, through the action of ATG7 
(E1-like) and ATG3 (E2- like) to form LC3-II (Rubinsztein, Marino, & Kroemer, 2011). 
 
 
Figure 7 - Schematic view of autophagy initiation steps and mechanisms of membrane elongation 
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Thus, the lipidated form of LC3 is finally attached to the growing autophagosome 
membrane, where it is kept during the whole process. For this reason LC3 is considered a 
reliable marker of the entire process and the quantification of its two forms can provide 
important information about autophagy induction and flux.	  LC3-II is required both on the 
outer and inner membranes of the nascent autophagosome. Once the cytoplasmic cargo is 
completely wrapped, the double membrane structure closes to become the mature 
autophagosome that finally fuses with lysosomes. This fusion generates the so-called 
autophago-lysosome, which digest the cargo and some of the components of the vesicle 
itself (Abounit et al., 2012). Indeed, the fusion between the outer autophagosomal 
membrane with the lysosomal one determines the degradation of the inner membrane and 
of the proteins that are associated with it. Because of the transient nature of the 
autophagosomes, the lifetime of LC3 and its homologues is rather short. This feature 
represents the main difference between the ubiquitin-proteasome system and the 
autophagy-lysosome one, where the fate of the ubiquitin and ubiquitin-like proteins is 
different. Indeed, while the ubiquitin proteasome pathway recycles ubiquitin molecules, 
the autophagy-lysosome system progressively loses the ubiquitin-like proteins (LC3s), 
forcing the cell to replenish them in order to maintain the autophagic flux.  
 
Autophagy is primarily considered to be a non-selective degradation pathway, but the 
significance of more selective forms of the process is becoming increasingly evident. 
Selective autophagy relies on cargo-specific autophagy receptors that facilitate cargo 
sequestration into autophagosomes. Autophagy receptors directly interact with the 
structure that needs to be specifically eliminated by autophagy, as well as with LC3 present 
in the internal surface of the growing autophagosomes. This interaction is mostly mediated 
through a specific amino acid sequence present in the autophagy receptors and commonly 
referred to as the LC3-interacting region. One of the most important and well-known 
ubiquitin-associated proteins that provide a link between autophagy and selective protein 
degradation is p62, also called sequestosome 1 (SQSTM1 but hereafter referred as p62). In 
this way p62 acts as a bridge between ubiquitinated proteins that has to be degraded and 
LC3-II located in the inner membrane of the autophagosome. Thus, since LC3-II in the 
inner autophagosomal membrane is degraded together with other cellular constituents by 
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lysosomal proteases, also p62 trapped by LC3 is destroyed during the normal happening of 
the process, accumulating only in case of the impaired autophagic flux (Ichimura & 
Komatsu, 2010). p62 is more linked to the autophagy-lysosome system rather than to 
ubiquitin-proteasome, being required in the targeting of dysfunctional mytochondria for 
lysosomal degradation in a specific form of the process called mitophagy. Moreover other 
organelles can be specifically targeted for autophagic degradation (nucleophagy, 
reticulophagy, ribophagy) supporting the idea that the cell presents strict criteria and high 
specificity for self-eating. 
1.4 Transcription factor EB 
The transcription factor EB (TFEB) is a member of the microphthalmia family of basic 
helix-loop-helix– leucine-zipper (bHLH-Zip) transcription factors (MiT family). The role 
of MiT family in the regulation of basic cellular processes has only recently become more 
clear. Recent evidences showed that TFEB has an important function in organelle 
biogenesis and metabolic processes; in particular an increased number of new works 
clarified the mechanisms leading to TFEB activation and its role in the regulation of 
lysosomal function and autophagy, both in vitro and in vivo. 
1.4.1 MiT family of transcription factors 
MiT/TFE (Microphthalmia/TFE) transcription factor family is a subfamily of basic/helix-
loop-helix/leucine zipper (bHLH-LZ) transcription factors. During past years four 
members have been identified: microphthalmia-associated transcription factor (MiTF), 
TFEB, TFE3 and TFEC (Steingrimsson, Copeland, & Jenkins, 2004). All members of the 
MiTF/TFE family share a similar structure that incluedes three critically important regions 
(Figure 8). They share an identical basic motif for binding to specific areas of DNA while 
they present highly similar HLH and Zip regions, which are instead critical for protein-
protein interactions. Homodimerization and heterodimerization within members of the 
MiTF/TFE family is critical for binding to DNA and transcriptional activation of target 
genes (Martina, Diab, Li, & Puertollano, 2014). TFEB, MITF and TFE3 also contain a 
conserved activation domain that is important for their transcriptional activation.  
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Figure 8 - Multialignement showing the different conserved region shared by all the four members of 
the MiT transcription factors family (Napolitano & Ballabio, 2016) 
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The activation domain is missing in TFEC, which is the most divergent member of the 
family and appears to inhibit, rather than activate, transcription (Napolitano & Ballabio, 
2016).  
MiT members bind the palindromic CACGTG E-box, a motif also recognized by other 
bHLH-Zip transcription factors, such as MYC, MAX and MAD proteins (Hemesath et al., 
1994); differently from other bHLH-Zip transcription factors, MiT proteins also bind the 
asymmetric TCATGTG M-box sequence. Binding to DNA sequences is possible through 
the formation of both homodimers and heterodimers with any other family member, as 
already mentioned. However, MiT proteins are not able to heterodimerize with other 
bHLH-Zip transcription factors because they present a specific conservation of three 
residues in the Zip domain that generates an unusual folding allowing the specific 
interaction among only MiT members, while preventing the binding to other bHLH-Zip 
transcription factors (Pogenberg et al., 2012). All this four members are conserved among 
vertebrates and a single orthologous gene is found also in lower organisms such as 
Drosophila melanogaster and Caenorhabditis elegans. 
In mammalian, each member has a typical expression pattern. MiTF is predominantly 
expressed in melanocytes, osteoclasts, macrophages and heart, whereas TFEC expression 
is restricted to of cells myeloid origins. In contrast, TFE3 and TFEB show a more 
ubiquitous expression and have been detected in multiple cell types (Martina et al., 2014).   
Plenty of evidences supports the important role played by this family of transcription 
factors in many cellular and developmental processes. MITF is critical for development, 
survival, and differentiation of neural crest-derived melanocytes and retinal pigmented 
epithelium (RPE) and collaborates with TFE3 to regulate osteoclastogenesis and mast cell 
differentiation (Martina et al., 2014). TFE3 was first identified as a protein that binds to the 
mE3 motif within the immunoglobulin heavy-chain enhancer and was implicated, together 
with TFEB, in humoral immunity. Finally, TFEB was shown to be essential for placental 
vascularization. 
Mutation and/or aberrant expression of several MiTF/TFE family members have been 
linked to different types of cancer in humans, such as renal carcinomas, alveolar sarcomas, 
and melanomas.  
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Furthermore, recent evidences suggest that some members of the family, in particular 
TFE3 and TFEB, function as critical factors in nutrient sensing and maintenance of cellular 
homeostasis. In particular, thanks to the hard work of prof. Ballabio and collaborators, it 
has emerged the role of TFEB in lysosomal homeostasis, autophagy regulation and energy 
metabolism. 
1.4.2 TFEB gene network and function 
As mentioned before, lysosomes are crucial components of the cellular degradation and 
recycling system, and their correct function is necessary to maintain proper cell 
homeostasis(Ballabio, 2016). These organelles are indeed involved in a number of 
essential cellular processes, including endocytosis, autophagy and lysosomal exocytosis 
(Medina et al., 2011; Settembre et al., 2013). Although lysosomes were originally 
described as static organelles devoted to terminal degradation of waste material and 
lysosomal biogenesis was considered as a housekeeping process, recent discoveries 
supporting the idea that lysosomal biogenesis and function are finely transcriptionally 
regulated changed the way of looking at these organelles. Microarray analysis revealed that 
genes encoding for lysosomal proteins are co-expressed in different cell types and under 
different conditions (Sardiello et al., 2009). Subsequent promoter analysis of lysosomal 
genes revealed that they share a common 10-base E-box-like palindromic sequence, the so-
called coordinated lysosomal expression and regulation (CLEAR) motif. TFEB has been 
identified as the candidate transcription factor that directly binds to CLEAR elements, 
thereby promoting the expression of the entire network of genes containing the CLEAR 
regulatory motif in their promoter (namely the CLEAR network) (Palmieri et al., 2011). 
Accordingly, TFEB overexpression in cell culture results in an increased number of 
lysosomes and higher levels of lysosomal enzymes, thus enhancing lysosomal catabolic 
activity.  
Altogether these findings indicate that TFEB is a master regulator of the lysosomal 
biogenesis program. Furthermore, through the regulation of TFEB activity, cells can 
monitor lysosomal function and adapt to degradation requirements and/or environmental 
signals.  
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Subsequent work has shown that TFEB is also able to orchestrate the expression of a 
broader number of genes, which are not only involved in lysosomal biogenesis and 
function, but also in autophagy and lysosomal exocytosis (Palmieri et al., 2011). In 
particular, TFEB has been shown to bind to the promoter regions and induce the 
expression of numerous autophagy genes important for autophagosome biogenesis and 
autophagosome-lysosome fusion (Settembre et al., 2011), supporting the transcription of 
these regulators that are normally degraded throughout the process. TFEB is not the only 
transcription factor implicated in autophagy regulation. FoxO3, HIF-1 and p53 have also 
been shown to regulate the expression of autophagy genes in response to different stress 
conditions; however, while these latter regulators promote genes involved in initial steps of 
autophagosome formation, TFEB appears to control a more comprehensive autophagy 
gene network, coordinating the two main degradative pathways of the cell.  
Moreover, TFEB has also been found to induce lysosomal exocytosis (Medina et al., 
2011), a process by which lysosomes fuse to the plasma membrane and secrete their 
content to the extracellular space.  
Importantly, TFEB does not regulate the basal transcription of its targets but rather 
enhances their transcriptional levels in response to environmental cues. Therefore, by 
modulating the processes of lysosomal biogenesis, autophagy and lysosomal exocytosis, 
TFEB coordinates a transcriptional program able to control the main cellular degradative 
pathways and to promote intracellular clearance.  
1.4.3 Regulation of TFEB activity 
Understanding the mechanisms regulating TFEB activation has been the first necessary 
step in order to exploit the different functions of this transcription factor to modulate 
cellular clearance in pathological conditions. The activity of TFEB is strictly regulated 
through post-translational modifications, protein–protein interactions and subcellular 
relocalization. So far, TFEB activation during nutrient deprivation has been the most 
studied model; in resting cells, under nutrient-rich conditions, TFEB is largely cytosolic 
and inactive. Conversely, upon starvation or under conditions of lysosomal dysfunction or 
stress, TFEB rapidly translocates to the nucleus and activates the transcription of its target 
genes (Settembre et al., 2011). In addition, TFEB activation also promotes its own 
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transcription, which represents an additional feedback-loop that further sustains lysosomal 
signaling and function.  
 TFEB cellular localization and activity are mainly controlled by its phosphorylation status. 
Two particular serine residues, Ser142 and Ser211, in the TFEB protein play a crucial role 
in determining its subcellular localization. When both of these two serine residues are 
phosphorylated, TFEB is kept inactive in the cytosol. Accordingly, variants of TFEB 
carrying Ser-to-Ala mutations of either Ser142 or Ser211 are always nuclear and 
constitutively active (Settembre et al., 2012). Phosphorylation of Ser211, in particular, has 
been shown to serve as a docking site for the chaperone 14-3-3, which sequesters TFEB in 
the cytosol and prevents its nuclear translocation, probably by masking its nuclear 
localization signal (NLS) (Martina, Chen, Gucek, & Puertollano, 2012).  
mTORC1 complex and ERK2, both master controllers of cellular growth, are the main 
protein kinases known to phosphorylate TFEB under nutrient-rich conditions in most cell 
types. Remarkably, mTORC1 activation occurs at the lysosomal membrane (Sancak et al., 
2010). In the presence of nutrients, a mechanism involving the v-ATPase complex 
promotes the activation of the small Rag (Ras-related GTP-binding) GTPases, which 
recruit mTORC1 to the lysosomal membrane, thus promoting its activation through the 
small GTPase Rheb. Interestingly, active Rag GTPases also bind to TFEB and recruit it to 
the lysosomal membrane, thereby promoting its phosphorylation by mTORC1. This 
evidence suggests that mTORC1- mediated TFEB phosphorylation can occur at the 
lysosomal membrane (Martina et al., 2014). Upon starvation or lysosomal stress, mTORC1 
is released from the lysosomal membrane and becomes inactive, reducing its inhibitory 
activity on TFEB and allowing potential phosphatases to act removing the inhibitory 
phosphorylation (Figure 9). Interestingly, starvation, through a calcium transient 
lysosome-dependent, activates the phosphatase calcineurin, which in turn 
dephosphorylates TFEB and promotes its nuclear translocation (Medina et al., 
2015). Moreover, in vivo data demonstrate that calcineurin is also promoting TFEB 
activation in skeletal muscle during exercise, suggesting a potential role for TFEB 
in controlling contraction-dependent adaptations to physical training.  
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In conclusion, further studies will be needed to fully understand how different pathways 
communicate with each other to modulate TFEB activity in order to finely tune the final 
transcriptional outcome.  
 
 
 
 
1.4.4 In vivo studies and potential role of TFEB as therapeutic target for disease 
TFEB tissue-specific functions, as well as the modulation of its activity, have been long 
investigated. TFEB-null mice die at embryonic stages, suggesting important role of this 
transcription factor during development. This lethality has precluded a systematic 
characterization of TFEB function in different tissues; therefore, the generation of 
conditional mouse models has been the only way to circumvent this problem. The use of 
Figure 9 - Scheme representing the signaling pathways converging on TFEB activity regulation (Shen & 
Mizushima, 2014)  
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such mice has revealed that TFEB surprisingly possesses specialized completely different 
functions in different tissues. 
Liver-specific deletion and viral-mediated overexpression of TFEB in the liver has 
revealed a central role for this protein in regulating liver lipid metabolism. TFEB has been 
shown to control lipid catabolism and to directly regulate the transcription of Pgc1α, a key 
regulator of energy metabolism. Indeed, TFEB depletion in liver results in impaired 
catabolism and exacerbated metabolic imbalance in obese mice, whereas TFEB 
overexpression has the opposite effect and rescues obesity and associated metabolic 
syndrome (Settembre et al., 2013). Moreover, our evidences using gain and loss of 
function approaches in skeletal muscle show that TFEB control glucose homeostasis and 
energy balance in this tissue during exercise.  
Nonetheless, due to its involvement in intracellular clearance pathways, TFEB has been 
studied as an appealing therapeutic target for many diseases associated with autophagic or 
lysosomal dysfunction and the accumulation of toxic aggregates.  
Indeed, induction of TFEB activity has already been successfully used as a therapeutic 
strategy in several disease models. Overexpression of TFEB in cellular and mouse models 
of several lysosomal storage disorders (LSDs), such as Pompe disease and others, has been 
shown to be beneficial in reducing substrate accumulation and improving autophagy and 
lysosomal function with a consequent amelioration of  the severity of tissue phenotype 
(Spampanato et al., 2013). 
Moreover also neurodegenerative diseases such as Parkinson’s and Alzheimer’s benefit 
from TFEB overexpression in the tissue involved in the pathology (Decressac et al., 2013). 
Indeed intracellular clearance of intracellular aggregates through autophagy reactivation 
and lysosomal exocytosis represents an appealing therapeutic strategy that, in any case, 
requires further investigations in order to understand the possible effects of long-term 
TFEB treatments. Indeed autophagy activation via MiT genes has been associated with 
tumorigenesis in different tissues. Therefore, alternative strategies, such as inducing TFEB 
activity for only limited periods and in a tissue specific context or enhancing only a 
specific subset genes of the TFEB-regulated network, should be considered when using 
TFEB as a therapeutic tool.  
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1.5 Exercise metabolism and the skeletal muscle adaptation  
The benefits provided by physical activity have long been known. Indeed, physical 
inactivity is a known, but modifiable, risk factor that contributes to lifestyle-related 
diseases, including many causes of ‘‘preventable death’’ (Booth, Roberts, & Laye, 2012). 
Regular exercise and physical activity have been proposed in the prevention, management, 
and treatment of numerous chronic conditions, including hypertension, coronary heart 
disease, obesity, type 2 diabetes mellitus (T2DM), and age-related muscle wasting 
(sarcopenia) (Egan & Zierath, 2013). Thus the axiomatic statement “exercise is medicine” 
appears to be always more convincing, placing physical activity at the top as preventive 
approach for metabolic syndromes. In fact, regular exercise combined with dietary 
intervention has been proved to be significantly more successful than pharmacological 
intervention in the treatment and prevention of obesity and T2DM (Knowler et al., 2002). 
While the benefits and adaptations to regular exercise are long known, molecular 
networks, signaling pathways and regulatory molecules that coordinate adaptive responses 
to exercise are still matter of debate. 
1.5.1 Molecular basis of skeletal muscle adaptation to exercise  
Due to its ability of contracting, skeletal muscle is the main protagonist of exercise training 
and training derived adaptations. Over time, skeletal muscle demonstrates remarkable 
malleability in functional adaptation and remodeling in response to contractile activity. 
Training-induced adaptations are reflected by changes in contractile protein and function, 
mitochondrial function remodeling, metabolic and glucose homeostasis regulation, 
intracellular signaling and transcriptional responses (Egan & Zierath, 2013).  
The widely accepted molecular mechanisms that govern adaptations to exercise training 
involve gradual alterations in protein content and enzyme activities. These progressive 
changes reflect activation and/or repression of specific signaling pathways that regulate 
transcription and translation of exercise-responsive gene. Transient post-exercise changes 
in gene transcription include genes involved in different muscle processes: myogenic 
regulators, genes of carbohydrate (CHO) metabolism, lipid mobilization regulators, 
transporters and mitochondrial biogenesis/oxidative phosphorylation modulators (Cartee, 
Hepple, Bamman, & Zierath, 2016). This gene expression modulation is achieved through 
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mainly through alteration of transcription factor binding activity, protein stability and/or 
regulation of subcellular localization of different transcription factors. However, although 
each individual bout of exercise is necessary as a stimulus for adaptation, it alone is 
insufficient to alter training-induced muscle phenotype; thus, adaptation is the consequence 
of repetition of the stimulus of individual exercise bouts (Figure 10). More specifically, an 
individual exercise bout elicits a rapid, but transient, increase in relative mRNA expression 
of a given gene after exercise, during recovery period. Alterations in mRNA expression are 
typically greatest at 3-12 hours after cessation of exercise session and generally return to 
basal levels within 24 hours; however the temporal pattern of expression is specific for any 
specific gene and typology of exercise, mainly relying on the different transcription factors 
that are activated during the contractile stimulus. Translational processing is reflected by 
elevated post-exercise protein synthesis rate that results in a modest change in protein 
content.  
 
 
Superimposition of repeated exercise bouts results in the gradual accumulation of protein 
in response to repeated, pulsed increases in relative mRNA expression. Thus, long-term 
Figure 10 - Schematic representation of the molecular basis of 
skeletal muscle adaptation to exercise. Intracellular events gradually 
modify gene expression, protein expression leading to the final 
adaptation and increased muscle performance (Egan & Zierath, 
2013) 
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adaptation to training is due to the cumulative effects of each acute exercise bout leading to 
a new functional threshold. Training-induced changes in protein content or enzyme 
function alter metabolic responses to exercise thus resulting in improved exercise 
performances time by time. Summarizing, these adaptations are intrinsic to the working 
skeletal muscle, and collectively contribute toward maximizing substrate delivery, 
mitochondrial respiratory capacity, and contractile function during exercise with the net 
effect of promoting optimal performance during a future exercise challenge. All these 
features finally result in a robust defence of homeostasis against metabolic and mechanical 
perturbation occurring during physical activity. 
1.5.2 Regulation of skeletal muscle gene expression during adaptation  
An increasingly well-defined network of transcription factors and co-regulator proteins has 
emerged, all regulating skeletal muscle plasticity through the integration of signals from 
physiological stimuli and coordinated metabolic adaptations. This network exerts 
molecular control over contractile, metabolic, and mitochondrial adaptation altering the 
expression of key enzymes in CHO and lipid metabolism and coordinating this with 
mitochondrial biogenesis in response to exercise (Hood, 2001).  
The process of mitochondrial biogenesis is complex and highly regulated, requiring the co- 
ordination and co-expression of genes belonging to both nuclear and mitochondrial 
genomes. Mechanistic studies using transgenic animals and pharmacological manipulation 
have explored the roles of key regulators of skeletal muscle phenotype. Many of them are 
sufficient to stimulate mitochondrial biogenesis, fiber-type transformation, and 
reprogramming of skeletal muscle metabolism, but many are not necessary for exercise-
induced skeletal muscle adaptation. For example, PGC1α acts as a transcriptional co-
activator through recruitment and co-regulation of multiple transcription factors that 
regulate skeletal muscle gene expression, including NRF-1, NRF-2, and Tfam (Lin, 
Handschin, & Spiegelman, 2005). Its overexpression in rodent skeletal muscle produces a 
phenotype remarkably similar to aerobically trained muscles, with increased mitochondrial 
density, respiratory capacity, ATP synthesis and improved exercise performances (Calvo et 
al., 2008).  However, adaptive responses after exercise training are similar in WT and 
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PGC1α KO animals (Leick et al., 2008), suggesting that this transcriptional co-activator is 
not necessary for the majority of adaptive responses to exercise training. 
Despite all these hunting for transcriptional regulators of mitochondrial biogenesis as 
consequence of exercise training, little is know about the gene expression regulation of 
glucose transporters and glucose homeostasis regulation. So far it is known that calcineurin 
phosphatase is playing a major role in the control of glucose uptake during physical 
training (Long & Zierath, 2008); moreover AMPK and nNOS signaling have been 
correlated to GLUT4-to-plasmalemma translocation during contraction (De Palma et al., 
2014). Nevertheless, a sensor able to transcriptionally coordinate mitochondrial and 
glucose homeostasis gene expression is missing. Indeed these are only two of the major 
adaptation induced by physical training that have been well studied for their important role 
in fighting metabolic syndromes such as 2TDM and skeletal muscle aging (Cartee et al., 
2016). 
Thus the possibility of discovering a master coordinator of exercise-induced metabolic 
adaptations would be for sure the first step for pharmacological intervention in order to 
have “exercise in a pill”. 
1.5.3 Modalities of exercise 
The use of the term “exercise” in the scientific community often encompasses several 
modifiable variables. These include the modality (e.g., aerobic versus resistance) and the 
frequency, intensity, and duration of exercise sessions, each of which modulating different 
factors impacting the metabolic and molecular responses. Aerobic (or endurance-based) 
and resistance (or strength-based) activities represent two extremes of the exercise 
continuum. Aerobic exercise imposes a high-frequency (repetition) and low-power output 
(load) demand on muscular contraction, whereas resistance exercise imposes a low-
frequency and high-resistance demand. As a consequence, the metabolic and molecular 
signatures of these different modalities are distinct, specifying a peculiar molecular 
response coupled to a functional outcome. Although both aerobic exercise and resistance 
training can individually promote substantial health benefits, divergent effects are observed 
depending on the parameter of interest. For example, aerobic training more effectively 
modifies cardiovascular risk factors, whereas resistance training more effectively 
Introduction 
 30 
maintains basal metabolic rate, muscle mass, and physical function in the elderly (Cartee et 
al., 2016). However, compared to either modality alone, a combination of aerobic and 
resistance training is more effective for reducing the insulin resistance and functional 
limitations in obesity and the metabolic syndrome (Davidson et al., 2009), improving even 
glycemic control in T2DM. 
1.5.4 Metabolic response to an acute bout of exercise 
During acute exercise, the contribution of various metabolic pathways to energy provision 
is determined by the relative intensity and absolute power output of the exercise bout. The 
absolute power output determines the rate of ATP demand and energy expenditure, 
whereas the relative exercise intensity influences the relative contributions to energy 
provision of carbohydrates (CHO), lipid sources and circulating/intramuscular fuel stores. 
The use of indirect calorimetry combined with isotope tracer methodology permitted the 
assessment of substrate utilization during exercise (van Loon, Greenhaff, Constantin-
Teodosiu, Saris, & Wagenmakers, 2001). Fuel utilization is finely quantitatively and 
temporally coordinated to meet the metabolic demands of exercise. 
At low-to-moderate intensities of exercise, the primary fuel sources supplying skeletal 
muscle energy demand are glucose, derived from hepatic glycogenolysis (or 
gluconeogenesis) and oral ingestion, and free fatty acids (FFAs) released by adipose tissue 
lipolysis. With respect to extramuscular fuel sources, as exercise intensity increases, 
muscle utilization of circulating FFAs declines modestly, whereas utilization of circulating 
glucose increases progressively up to near-maximal intensities. This is paralleled by an 
increase in the absolute rates of CHO oxidation and relative contribution to energy 
provision, with a majority of energy being provided by muscle glycogen at high intensities 
of exercise. When exercise at a fixed sustained intensity is prolonged (>60 minutes), an 
increasing energy contribution is derived from lipid oxidation. Consequently, the 
proportion of energy derived from muscle glycogen declines and is replaced by a 
progressive increase in plasma FFA oxidation. Thus, muscle glycogen is the predominant 
CHO source during moderate to intense exercise, and the rate of glycogenolysis is 
proportional to the relative exercise intensity. Conversely, intramuscular triglycerides 
(IMTGs) constitute only a small fraction (1-2%) of whole-body lipid stores; however they 
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constitute an important fuel source during prolonged (>90 minutes), moderate intensity 
exercise, providing 25% of total energy. As with aerobic exercise, both muscle glycogen 
and IMTG contribute to energy provision during resistance; however, regulation of CHO 
and lipid utilization during exercise is still a matter of open debates (Egan & Zierath, 
2013). 
 
 
1.5.5  Muscle metabolism during the post-exercise recovery period 
After the cessation of exercise, the metabolic rate declines but remains slightly elevated 
(<10%) for up to 24 hr. The extent of this ‘‘excess postexercise oxygen consumption’’ 
(EPOC) is proportional to the metabolic stress and determined by the intensity, duration, 
and type of exercise bout (Borsheim & Bahr, 2003) and this feature is the basis of the 
beneficial effect of exercise in increasing insulin-sensitivity. 
This recovery period is characterized mainly by two major phases: (1) recovery of 
myocellular homeostasis in the immediate hours after exercise, and (2) cellular 
contributions to adaptation to exercise.  
In contrast to the reliance on CHO metabolism during exercise, an increase in lipid 
oxidation and “sparing” of CHO sources for energy provision occurs during the recovery 
period. This shift accommodates the high metabolic priority of resynthesizing muscle 
glycogen storage, whereas the oxidation of lipid from both IMTG and circulating FFA 
Figure 11 - Schematic tracks representing different fuel utilization in dependence of exercise intensity (A) or exercise 
duration at a fixed intensity (e.g. 65% VO2max) (B). RER (respiratory exchange ratio) is the ratio between carbon dioxide 
produced and oxygen consumed; it is the index used to estimate the contribution of different fuel to energy production 
(Egan & Zierath, 2013) 
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sources is elevated to meet fuel requirements. The prolonged elevation in lipid oxidation in 
the post-exercise period represents a key event in exercise-mediated effects on whole-body 
lipid metabolism, mediating beneficial effects of exercise in obese people. Lipid oxidation 
rates can reach 25% of that reported during exercise, and contribute greater than 60% of 
oxidative metabolism during recovery. Several other biosynthetic processes contribute to 
homeostatic recovery at a local level, including elevated rates of mitochondrial and 
myofibrillar protein synthesis.  
In contrast to the rapid glycogen depletion during sustained or prolonged exercise, the 
replenishment of muscle glycogen to pre-exercise levels requires 24-48 hours and can be 
heavily altered by dietary interventions. Indeed, high CHO intake in the recovery period 
often produces a “supercompensation” effect in which glycogen repletion markedly 
exceeds pre-exercise concentrations.  
1.5.6 Activity dependent signaling pathways 
Skeletal muscle contraction leads to a dramatic perturbation in mechanical strain, ATP 
turnover, calcium fluxes, redox balance and intracellular oxygen pressure; all these 
changes have been implicated in the activation of signal transduction cascades regulating 
skeletal muscle plasticity. In turn, various cellular stress sensors transduce these 
homeostatic perturbations in transcriptional alterations providing a framework, known as 
excitation-transcription coupling (Figure 12), that integrates signaling events regulated by 
cellular bioenergetics and stress and the expression of genes that dictate skeletal muscle 
phenotypic adaptation to exercise training.  
 
One of the first perturbations of cellular homeostasis occurring during contraction involves 
calcium and its related signaling. Upon action potential arrival, sarcolemma undergoes a 
strong depolarization that in turn allows a massive calcium release from reticulum inside 
the myofiber. This calcium transient is essential to allow the interaction between myosin 
and actin and therefore to activate muscle contraction. Nevertheless, calcium oscillations 
during contractions lead to the activation of different signaling pathways involved in the 
determination of fiber type. In particular the Ca2+-calmodulin complex is known to activate 
numerous downstream signaling kinases and phosphatases such as CaMK and calcineurin 
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(Cn). Calcineurin has a pivotal role in the regulation of the slow gene program. Indeed, the 
overexpression of an activated form of Cn leads to small increase in slow fibers, while the 
genetic ablation of Cn in skeletal muscle prevents a fast-to-slow fiber-type transformation 
during overload hypertrophy (Parsons et al., 2004). Activated Cn dephosphorylates many 
substrates including the nuclear factor of activated T cells (NFAT), the myocyte enhancer 
factor 2 (MEF2) transcription factors and TFEB. Translocation of NFAT into the nucleus 
induces a slow gene program inhibiting the fast program while MEF2 activation, together 
with various co-factors, plays an important role in the regulation of fiber type metabolism, 
activating the well-known transcriptional co-regulator PGC1α.  
The role of Cn in dephosphorylating TFEB has been recently published (Medina et al., 
2015) even if the evidences clarifying the meaning of this TFEB nuclear translocation have 
not yet been published and will be discussed throughout all the Results section. 
 
Another important pathway activated during exercise is mediated by the action of the 
kinase AMPK. This serine/threonine kinas, activated thanks to an increase in the 
AMP/ATP ratio, modulates acutely cellular metabolism through phosphorylation of 
metabolic enzymes (Jager, Handschin, St-Pierre, & Spiegelman, 2007). Given the rate of 
ATP turnover during contraction, AMPK functions as a signal transducer that responds to 
an altered cellular energy status in order to provide metabolic adaptations (Egan & Zierath, 
2013). AMPK activation acts to conserve ATP by inhibiting biosynthetic and anabolic 
pathways, stimulating catabolic conditions to restore energy homeostasis. In skeletal 
muscle acute AMPK activation stimulates an increase in insulin-indipendent glucose 
transport, due to the translocation of GLUT4 to the membrane (Merrill, Kurth, Hardie, & 
Winder, 1997). Several studies have shown that AMPK is a negative regulator of skeletal 
muscle protein synthesis and consequent growth; indeed, AMPK phosphorylates tuberous 
sclerosis complex 2 (TSC2) and also directly mTORC1, leading to an inhibition of 
translation initiation. Besides its role in repressing protein synthesis, AMPK activation also 
stimulates protein degradation through phosphorylation and activation of FoxO3 and 
stimulating the ubiquitin-proteasome and the autophagy-lysosome systems. Chronic 
AMPK activation alters metabolic gene expression and induces mitochondrial biogenesis 
phosphorylating the well-known co-regulator PGC1α (Jager et al., 2007).  
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Figure 12 - Schematic of excitation-transcription coupling in skeletal muscle (Egan & Zierath, 2013)  
 
Exercise is also a potent autophagy activator in skeletal muscle (Grumati, Coletto, Sandri, 
& Bonaldo, 2011; He et al., 2012). Autophagy is normally constitutively active in adult 
skeletal muscle even if at a low rate. In this tissue, different stimuli, such as starvation and 
denervation-induced atrophy can strongly induce this process, as well as muscle 
contraction.  
Autophagy is not required to sustain physical training but it is fundamental in the recovery 
period to remove damaged mitochondria and structures produced during contraction (Lo 
Verso, Carnio, Vainshtein, & Sandri, 2014; Vainshtein & Hood, 2016). Indeed, since 
mitochondria produce the energy required for muscle contraction, their proper integrity is 
essential to maintain muscle homeostasis. The mechanical and energetic perturbations 
associated with exercise result in immediate increase in ROS in skeletal muscle that in turn 
can irreversibly damage mitochondria. Thus, in an effort to prevent cell death, damaged 
mitochondria are sequestered by autophagosomes and degraded before apoptosis or 
necrosis can be triggered.  
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Beside the above described mechanisms, other pathways are usually active during 
contraction, all of them depending on a different stimulus such as redox stress, mechanical 
loading and oxygen unbalance. 
It is noteworthy to mention the new emerging role of skeletal muscle during exercise as a 
secretory organ that secretes cytokines and exosomes in the circulation system (Glund et 
al., 2007; Safdar, Saleem, & Tarnopolsky, 2016). The understanding of skeletal muscle 
endocrine function and the crosstalk among this and other organs will be for sure a fertile 
avenue for future research. 
In conclusion, the pleiotropic effects of exercise and the complexity of responses at both 
metabolic and molecular level suggest that there is no singular pathway mediating 
exercise-training adaptations. For these reasons, all these highlights are far from the 
possibility to be condensed in pharmacological therapy that can be used as an “exercise 
mimetic”. However, compounds actives on particular exercise-activated pathways could be 
for sure used as adjunct treatment to exercise to potentiate or ameliorate a particular 
adaptive response. 
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2 Aim of the study 
 
 
Skeletal muscle is a highly dynamic tissue able to adapt to different physiopatological 
stimuli. However molecular mechanisms that lead to myofibers adaptations to exercise  are 
still under debate. It is also well established the role of exercise in promoting 
mitochondrial biogenesis and increasing mitochondrial performances; furthermore 
substrate utilization and glucose uptake are deeply influenced by physical training. 
Nevertheless, a common regulator able to coordinate substrate absorption and 
mitochondrial fuel utilization was still missing. 
 
My PhD project has been focused on the dissection of the role of the transcription factor 
EB in skeletal muscle. Based on our findings proving that its activity is promoted during 
muscle contraction, we tried to clarify the meaning of this context specific activation.  
Thus, I was involved in a project aimed to dissect the role of this transcription in skeletal 
muscle. By mean of gain and loss of function approaches we went through the 
understanding of the gene network controlled by TFEB, giving a new perspective on this 
transcription factor, till now known mainly because of its pivotal role in autophagy 
regulation.  
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3 MATERIALS AND METHODS 
 
3.1 High-content nuclear translocation assay 
 
HeLaTFEB-GFP cells were reverse transfected in 96 or 384-well plates, incubated for 12h, 
starved, washed, fixed and stained with DAPI. For the acquisition of the images, at least 5 
images fields were acquired per well of the 96/384-well plate by using confocal automated 
microscopy (Opera high-content system; Perkin-Elmer). A dedicated script was developed 
to perform the analysis of TFEB localization on the different images (Harmony and 
Acapella software; Perkin-Elmer). The script calculates the ratio value resulting from the 
average intensity of nuclear TFEB–GFP fluorescence divided by the average of the 
cytosolic intensity of TFEB–GFP fluorescence. The results were normalized using 
negative (RPMI medium) and positive (HBSS) control samples in the same plate. At least 
two independent experiments, and up to 3,000 individual cells per treatment from at least 
two independent wells, are routinely analysed. P values were calculated on the basis of 
mean values from independent wells. The data are represented by the percentage of nuclear 
translocation versus the indicated control using Excel (Microsoft) or Prism software 
(GraphPad software).  
The TFEB–GFP nuclear translocation analyses of different populations of transfected cells 
(detected by immunofluorescence of tagged-plasmids) were performed by a modified 
script that calculates the ratio value resulting from the average intensity of nuclear TFEB–
GFP fluorescence divided by the average of the cytosolic intensity of TFEB–GFP 
fluorescence on both positive-transfected and negative-transfected cells.  
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3.2 Cell culture, plasmids, siRNA transfection and drugs 
tratments 
 
Stable HeLaTFEB-GFP cell line was previously described (Settembre et al., 2012). HeLa cells 
were cultured in DMEM or RPMI 1640 media supplemented with 10% fetal bovine serum, 
200 µM L-glutamine, 100 µM sodium pyruvate, in 5% CO2 at 37°C.  
Cells were silenced with PPP3CB siRNA oligonucleotides (Ambion, 4390824) or non-
targeting siRNAs (Thermo, D-001810-10-05), by direct or reverse transfection, using 
Lipofectamine RNAiMAX reagent (Invitrogen) according to the protocol from the 
manufacturer. siRNA-transfected cells were collected after 72 h, if not otherwise stated. 
The plasmid carrying a constitutively active form of the human calcineurin catalytic 
subunit (ΔCnA) was donated by B. Rothermel (The University of Texas Southwestern 
Medical Center, USA). Cells were transfected using Lipofectamine LTX – Plus reagent 
(Invitrogen) according to the protocol from the manufacturers. The following drugs were 
used: FK506 (5µM, otherwise indicated) and cyclosporine A (10 µM, otherwise indicated). 
Starvation medium was HBSS, 10 mM HEPES. 
 
3.3 In vivo skeletal muscle electroporation, plasmids and IF 
Animals were handled by specialized personnel under the control of inspectors of the 
Veterinary Service of the Local Sanitary Service (ASL 16— Padova), the local officers of 
the Ministry of Health. Mice were housed in individual cages in an environmentally 
controlled room (23 °C, 12-h light– dark cycle) with ad libitum access to food and water. 
All procedures are specified in the projects approved by the Italian Ministero Salute, 
Ufficio VI (authorization numbers C65) and by the Ethics Committee of the University of 
Padova. All experiments were performed on 3- to 4-month-old C57BL/6J male mice. In 
vivo transfection experiments were performed by i.m. injection of expression plasmids in 
Tibialis Anterior (TA) muscles followed by electroporation. Animals were anesthetized by 
an intraperitoneal injection of xylazine (Xilor) (20 mg/Kg) and Zoletil (10 mg/Kg). TA 
muscles were isolated through a small hindlimb incision, and DNA was injected along the 
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muscle length. Electric pulses were then applied by two stainless steel spatula electrodes 
placed on each side of the isolated muscle belly (50 Volts/cm, 5 pulses, 200 ms intervals). 
10 days after transfection mice performed concentric exercise on a treadmill (LE 8710 
Panlab Technology 2B, Biological Instruments), with a 10 incline, until they were 
exhausted and then were euthanized.Muscles were removed and frozen in liquid nitrogen 
for subsequent analyses.  
TA muscles were transfected with the following different plasmids:  
• full-length TFEB-GFP 
•  ΔCnA;  
• CnB;  
• myc-CAIN.  
 
3.4 Immunofluorescence  
Frozen muscle serial sections (7 µm) were fixed in 4% paraformaldehyde in PBS 
for 10 min, washed twice in PBS (Sigma-Aldrich) for 5 min at room temperature 
(RT), and incubated in 0.3% TritonX-100 in PBS for 2 min at RT. After washing in 
PBS, sections were incubated in blocking solution (10% normal goat serum, 5% 
BSA in PBS) for 1h at RT. Anti-Dystrophin (Abcam) or anti-myc (Cell Signaling) 
were added separately to each serial section for 16 h at 4°C. Sections were washed 
twice in PBS, incubated with anti-rabbit Cy3 for 1 h at RT, washed twice, incubated 
with DAPI and then mounted with Elvanol. 
 
3.5 Acute exercise, mild exercise and training protocols 
For acute exercise, 3-5 moths-old mice were subjected to concentric exercise consisting of 
one day running on a treadmill (Biological Instruments, LE 8710 Panlab Technology 2B) 
to exhaustion, with a 10 degree decline, at increasing velocity, according to the protocol of 
exercise previously described (He et al., 2012). Briefly, exercise consists in 17 cm/sec for 
40 minutes, 18 cm/sec for 10 min, 20 cm/sec for 10 min, 22 cm/sec for 10 min, and then 
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increasing velocity of 1cm/sec and or 2 cm/sec alternatively every 5 minutes, until they 
were exhausted. Exhaustion was defined as the point at which mice spent more than 5 s on 
the electric shocker without attempting to resume running.  
Mild exercise was performed letting mice running on the treadmill for 1 hour at 15 cm/sec 
speed for 4 days. Training was performed for a total of 7 weeks increasing the speed of 5 
cm/sec every week. The starting speed was the 50% of the maximal speed (exhaustion test) 
that corresponded to 25cm/sec and the final speed reached at the end of the training period 
was 55 cm/sec.  
 
3.6 Generation of muscle-specific TFEB Knockout and 
inducible muscle-specific transgenic mice and AAV 
infection procedures 
Mice bearing Tcfeb-floxed alleles (Tcfebf/f ) (Settembre et al., 2013)were crossed with 
transgenic mice expressing Cre either under the control of a Myosin Light Chain 1 fast 
promoter (MLC1f-Cre) (Bothe, Haspel, Smith, Wiener, & Burden, 2000). For all 
experiments involving TFEB-KO mice, control mice were mice Tcfebf/f that did not carry 
the MLC1f-Cre transgene.  
To generate inducible muscle-specific TFEB transgenic animals, a line carrying 
Tcfeb3XFlag cDNA inserted after a CAGCAT cassette [chicken actin promoter (CAG) 
followed by chloramphenicol acetyltransferase (CAT) cDNA flanked by 2 loxP sites] 
(Settembre et al., 2011) was crossed with transgenic mice expressing Cre-ER driven by 
human skeletal actin promoter (HSA) (McCarthy, Srikuea, Kirby, Peterson, & Esser, 
2012). Tamoxifen- induced Cre LoxP recombination was activated by IP injection of 
tamoxifen-containing for 3 days. Muscles were collected 2 weeks after the tamoxifen 
treatment. Cre-negative littermates, also receiving tamoxifen treatment, were used as 
controls. Adult mice (3 to 5 months-old) of the same sex and age were used for each 
individual experiment. 
The PGC1α Knockout mouse line was obtained from Jackson Laboratory (Bruce 
Spiegelman, Dana- Farber Cancer Institute) (Lin et al., 2004). 
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In vivo TFEB overexpression experiments were performed by i.m. injection of a total dose 
of 1011 GC of AAV2.1 vector preparation. Muscles were removed 21 days after injection 
and frozen in liquid nitrogen for subsequent analyses.  
 
All mice used were males and maintained in a C57BL/6 strain background. Standard food 
and water were given ad libitum. Mice were maintained in a temperature - and humidity-
controlled animal-care facility, with a 12 hr light/dark cycle and free access to water and 
food (Standard Diet, Mucedola, Italy). All experiments were performed on 3- to 5-month-
old male mice; mice of the same sex and age were used for each individual experiment.  
For fasting experiments, control animals were fed ad libitum; food pellets were removed 
from the cages of the fasted animals. All procedures were formerly approved by the Italian 
Public Health, Animal Health, Nutrition and Food Safety, Italian Ministry of Health. 
 
3.6.1 Genotyping of muscle specific TFEB knockout and transgenic mice  
Mice were identified by analyzing the presence of Cre-recombinase on genomic DNA and 
by the presence of floxed Tcfeb allele (Tcfebf/f) for KO animals and Tcfeb3xFLAG for 
transgenic animals. Cre recombinase was always kept heterozygous in order to avoid 
aspecific recombination. Tcfeb floxed allele was maintained in a homozygous background 
with Cre heterozygous. Transgenic mice were obtained keeping both Cre and 
Tcfeb3XFLAG allele heterozygous. 
Caudal biopsies were lysed in the following lysis buffer containing Tris-HCL 1M pH 7.5 
and Proteinase K 10mg/mL (Life Technologies). Samples were incubated for 1 hour at 
57°C and then the proteinase K was inactivated at 99°C for 5 minutes. PCR protocol for 
Cre, Tcfebf/f and Tcfeb3XFLAG have been described in (Milan et al., 2015; Settembre et 
al., 2013). 
 
3.7 Microarray data processing  
The data discussed in this work have been deposited in NCBIs Gene Expression Omnibus 
(GEO) and are accessible through GEO Series accession number GSE62975 
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(TFEB_overexpression muscle dataset) and GSE62976 (TFEB-KO_muscle dataset). The 
two muscle studies (GSE62975 and GSE62976) are part of the SuperSeries GSE62980.  
The SuperSeries has been named: Expression data from mice after knockout or 
overexpression of Tcfeb in muscle. Low-level analysis to convert probe level data to gene 
level expression was performed using Robust Multiarray Average (RMA) implemented 
using the RMA function of the Bioconductor project. 
3.7.1 Statistical analysis of differential gene expression  
For each gene, a Bayesian t-test (Cyber-t) (Baldi & Long, 2001) was used on RMA 
normalized data to determine if there was a significant difference in expression between 
mice overexpressing TFEB (TFEB overexpression muscle mice) versus not-injected mice 
used as control and Tcfeb knock-down (KO) mice muscle-specific versus WT mice. P-
value adjustment for multiple comparisons was done with the False Discovery Rate (FDR) 
of Benjamini-Hochberg. The threshold for statistical significance chosen for both muscle 
microarray datasets analysis was FDR<0.05; a further filtering was performed for TFEB 
overexpression muscle dataset (GSE62975) by selection genes with an absolute Fold 
Change ≥1.5 for both increased (up- regulated genes) and decreased (down-regulated 
genes) expression levels.  
3.7.2 Microarray data analysis  
Gene Ontology Enrichment Analysis (GOEA) (Dennis et al., 2003)was performed for each 
microarray dataset on the up-regulated and down-regulated gene lists, separately, by using 
the DAVID online tool (DAVID Bioinformatics Resources 6.7) restricting the output to all 
Biological Process terms (BP_ALL) and to all Cellular Compartments terms (CC_ALL). 
The threshold for statistical significance of GOEA was FDR≤10% and Enrichment Score 
≥1.5.  
 
3.8 Electron microscopy 
 Small pieces of muscle tissue were fixed in a mixture of 2% paraformaldehyde and 1% 
Glutaraldehyde prepared in 0.2 M Hepes. Samples were suddenly post-fixed in a mixture 
of osmium tetroxide and potassium ferrocyanide, dehydrated in ethanol and 
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propyleneoxide and embedded in epoxy resin as described previously(Polishchuk et al., 
2014). Thin 65 nm sections were cut using a Leica EM UC7 ultramicrotome. EM images 
were acquired using a FEI Tecnai-12 electron microscope (FEI, Eindhoven, Netherlands) 
equipped with a VELETTA CCD digital camera (Soft Imaging Systems GmbH, Munster, 
Germany). Morphometric analysis of number and size of mitochondria was performed 
using iTEM software (Olympus SIS, Germany). Number of mitochondria was counted 
using the same magnification within 100 µm square field of view. For each experiment, 
between 154 and 196 individual mitochondrial diameters were measured from 3 mice per 
group.  
 
3.9 Biochemical Analysis of Mitochondrial Respiratory Chain 
Complex 
All these experiments were performed in collaboration with the laboratory of prof. Zeviani 
(MRC-Mitochondrial Biology Unit, Cambridge, UK).  
Muscle samples stored in liquid nitrogen were homogenized in 10 mM phosphate buffer 
(pH 7.4), and the spectrophotometric activity of cI, cII, cIII and cIV, as well as CS, was 
measured as described in (Bugiani et al., 2004). More in detail, complex I activity was 
measured using 50 µg mitochondrial protein in a reaction containing 250 mM 
sucrose, 2 mM EDTA, 100 mM Tris–HCl pH 7.4, between 10 and 100 µM decyl-
ubiquinone and 2 mM KCN at 30° C. Reactions were started by the addition of 50 
µM NADH and oxidation was followed at 340 nm for 2 minutes. Rotenone was 
used to block any rotenone insensitive activity. Complex II activity was measured 
by incubating 40 µg of mitochondrial protein at 30° C in a reaction mix containing 
50 mM KH2PO4, pH 7.4, 20 mM succinate, 2 µg/mL antimycin A, 2 µg/mL 
rotenone, 2 mM KCN and 50 µM 2,6-dichlorophenolindophenol (DCPIP). 
Reactions were initiated by adding 50µM DB to the reaction and followed 
measuring the change in absorbance at 600 nm for 2 min. Complex III activity is 
measured by incubating 20 µg mitochondrial proteins at 30° C in a reaction mix 
containing 250 mM sucrose, 50 mM Tris–HCl, 1 mM EDTA, 50 µM cytochrome c 
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and 2 mM KCN. Decylubiquinol (DBH2) was used an electron donor. The reaction 
was started by the addition of 50 µM DBH2 and the change in absorbance of 
cytochrome c at 550 nm was followed for 2 min. 5 µg of antimycin A were added to 
duplicate reactions to measure any antimycin A-insensitive activity. Complex IV 
activity was measured by adding 10 µg mitochondria to a mix containing 10 mM 
KH2PO4, pH 7.2 and between 5 and 50 µM ferrocytochrome c. The rate of 
oxidation of ferrocytochrome c was recorded for 2 min (extinction coefficient of 
27.2 mM− 1 cm− 1). Citrate synthase activity was measured at 30° C by using 10 
µg mitochondria to a reaction mixture containing 125 mM Tris–HCl, 100 µM 
DTNB (5,5′-dithiobis(2-nitrobenzoic acid) and 300 µM acetyl coenzyme A. The 
reaction is initiated by the addition of 500 µM oxaloacetate, and DTNB reduction at 
412 nm was measured for 2 min. The mitochondrial respiratory chain activities 
were expressed as nmoles/min/mg of protein.  
 
3.10 ATP quantification in skeletal muscle 
 
For the quantitative determination of Adenosine 5’triphosphate (ATP) gastrocnemius 
muscle samples stored in liquid nitrogen were homogenized in sterile water and analyzed 
according to the manufacturer’s instructions of ATP Bioluminescent Assay Kit (Sigma-
Aldrich).  
 
3.11 Isolation of skeletal myofibers and measurements of 
mitochondrial membrane potential 
Muscle fibers were isolated from FDB muscle and mitochondrial membrane potential 
measured by epifluorescence microscopy on the basis of the accumulation of TMRM 
fluorescence, as previously described (Lo Verso et al., 2014). Fibers were considered as 
depolarizing when they lost more than 10% of the initial value of TMRM fluorescence. 
Imaging was performed with a Zeiss Axiovert 100 TV inverted microscope equipped with 
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a 12-bit digital cooled charge-coupled device camera (Micromax, Princeton Instruments). 
The results were analyzed with MetaFluor imaging software (Universal Imaging). 
 
3.12 Mitochondrial respiration assay  
Mitochondria from mouse skeletal muscle were isolated as described (Frezza, Cipolat, & 
Scorrano, 2007). The rate of mitochondria oxygen consumption was measured at 30°C in 
an incubator chamber with a Clark/type O2 electrode filled with 2ml of incubation medium 
(125 mM KCl, 10 mM Pi.Tris, 20 mM Tris-HCl, 0,1 mM EGTA, ph 7,2). All measured 
were performed using mitochondria (0,2 mg mitochondrial protein/ml) incubated either 
with glutamate (5 mM)/ malate (2,5 mM) or /and succinate (5 mM) as substrates, in the 
presence (state 3) and in absence (state 4) of 100 mM ADP (Frezza et al., 2007). 
 
3.13 Morphological Analysis  
For SDH activity, 10µm thick sections from frozen tissue were collected on 
coverslips. The reaction mix contained: 5 mM phosphate buffer pH 7.4, 5 mM 
EDTA, 1 mM KCN, 0.2 mM Phenazine methosulfate (PMS), 50 mM Succinic acid, 
1.5 mM Nitro blue tetrazolium (NBT). Sections were incubated for 20 min at 37° C. 
PAS staining was performed in 10µm thick sections from frozen tissue. Briefly, 
sections were fixed in Carnoy’s solution for 10 minutes at room temperature (RT), 
washed three times in water and incubated for 5 minutes in 0.5% periodic acid. 
After washes section were allowed to react with Schiff’s reactive, washed again, 
dehydrated and mounted with the appropriate mounting medium.  
For cross sectional area detection, sections were immunolabeled with dystrophin antibody 
as previously described. Cross-sectional area was measured using ImageJ software in at 
least 1000 fibers and compared with the area of age-matched control. Images were 
captured using a Leica DFC300-FX digital charge-coupled device camera by using Leica 
DC Viewer software and morphometric analyses were made using the software ImageJ 
1.47 version. The total myofiber number was calculated from entire muscle section based 
Methods 
 48 
on assembled mosaic image (×20 magnification). Fyber typing was determined by 
immunofluorescence using combinations of the following monoclonal antibodies from 
DSHB: BA-D5 for type 1 MyHC isoform, SC-71 for type 2A MyHC isoform and BF-F3 
for type 2B. 2X fybers were calculated by difference. Images were captured using a Leica 
DFC300-FX digital charge-coupled device camera by using Leica DC Viewer software, 
and morphometric analyses were made using the software ImageJ 1.47 version.  
 
 
3.14 Immunohistochemistry  
Frozen muscle serial sections (7 µm) were fixed in 4% paraformaldehyde in PBS 
for 10 min, washed twice in PBS (Sigma-Aldrich) for 5 min at room temperature 
(RT), and incubated in 0.03% H2O2 in Methanol for 10 min at RT. After washing in 
PBS, sections were incubated in blocking solution (10% normal goat serum, 5% 
BSA in PBS) for 1h at RT. Anti-TFEB mAb (Bethil Laboratories) was added 
separately to each serial section for 16 h at 4°C. Sections were washed twice in 
PBS, incubated with biotin-conjugated (goat anti-rabbit IgG1, 5 µg/ml with 1% 
normal goat serum and 0,5% BSA in PBS) for 2 h at 4°C, washed twice, incubated 
with HRP-conjugated streptavidin (NovaRED substrate kit for peroxidase) (Vector 
Laboratories), following the manufacturer instructions. Slices were then rinsed in 
distilled water for 5 min, and counterstained with hematoxylin.  
 
3.15 Western Blot Analysis and Antibodies 
Total homogenates were prepared in Lysis buffer (50 mM Tris HCl [pH 8], 150 mM NaCl, 
1% TritonX-100, 2% SDS) with the addition of a protease and phosphatase inhibitor 
cocktail (Roche). Protein concentration was determined with BCA kit (Pierce). 50 µg of 
total protein lysate were run through a SDS-PAGE and electroblotted onto a PVDF 
membrane, which was then matched with different antibodies. The following antibodies 
were used: anti-GAPDH (cat. sc-32233) anti-nNOS (cat. sc-648) from Santa Cruz 
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Biotechnology; anti-Gys (cat. 3886), anti-pGys (cat. 3891) , anti-AMPK (cat.2532), anti-
pAMPK (cat. 2531), anti-pACC (cat. 3661) from Cell Signaling; anti-LC3B (cat. L7543), 
anti-p62 (cat. P0067) from Sigma Aldrich.  
 
3.16 Whole Body Indirect Calorimetry.  
Mice were individually housed in the chamber with a 12-h light/12-h dark cycle in an 
ambient temperature of 22–24° C. VO2 and VCO2 rates were determined under Oxymax 
system settings as follows: air flow, 0.6 l/min; sample flow, 0.5 l/min; settling time, 6 min; 
and measuring time, 3 min. The system was calibrated against a standard gas mixture to 
measure O2 (VO2) consumed and CO2 (VCO2) generated. Energy expenditure (EE), oxygen 
consumption (VO2) and CO2 generated (VCO2) during running was determined as described 
by Shemesh (Shemesh et al., 2014). Briefly, mice were acclimatized to a treadmill 
(Columbus Instruments) by running at 10 m/min for 15 min over three consecutive days. 
On the fourth day, groups of mice were run at 10 m/min, progressing to 15 m/min. Energy 
expenditure, oxygen consumption (VO2) and carbon dioxide production (VCO2) were 
recorded during running intervals, and the total distance run to exhaustion was determined. 
 
3.17 Plasma metabolites analysis. 
Blood was collected from the orbital plexus. Plasma or serum were prepared and frozen in 
aliquots at −20° C or used immediately after collection. A specific enzymatic kit was used 
for determination lactate (Abcam). Plasma glucose was monitored by a glucometer. Insulin 
was measured by ELISA (Millipore) following manufacturer indications. 
 
3.18 Tissue metabolites quantification  
Muscle free fatty acids were extracted as follows: briefly, pulverized muscle was 
homogenized in PBS, then extracted using chloroform/methanol (2:1), dried overnight and 
re-suspended in a solution of 60% butanol 40% Triton X-114/methanol (2:1). 
Measurements were normalized to protein content in the initial homogenate by DC protein 
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assay (Bio-Rad). The quantitative determination of glycogen amount was performed 
according to the manufacture’s instruction of the Glycogen	   Colorimetric/Fluorometric	  Assay	  Kit	  (BioVision). 
 
3.19 In Vivo Assessment of Insulin Action and Glucose 
Metabolism 
Four days before the experiment, the mice were anesthetized and an indwelling catheter 
was introduced in the left internal jugular vein. The mice were fully recovered from the 
surgery before the in vivo experiments, as reflected by their reaching preoperative weight. 
After an overnight fast, EU clamps were conducted in conscious mice as previously 
described (Zong, Armoni, Harel, Karnieli, & Pessin, 2012). 
The 2-h EU clamp was conducted with a prime continuous infusion of human insulin (4 
mill units/kg/min) and a variable infusion of 25% glucose to maintain glucose at <150 
mg/dl. Insulin stimulated whole body glucose metabolism was estimated using a prime 
continuous infusion of [3-3H] glucose (10 µCi bolus, 0.1 µCi/min; PerkinElmer Life 
Sciences). To determine the rate of basal glucose turnover, [3-3H] glucose (0.05 µCi/min) 
was infused for 2 h (basal period) before starting the EU clamp, and a blood sample was 
taken at the end of this basal period. To assess insulin- stimulated tissue-specific glucose 
uptake, 2-deoxy-d-[1-14C] glucose (PerkinElmer Life Sciences) was administered as a 
bolus (10 µCi) 75 min after the start of the clamp. Blood samples were taken at 80, 90, 
100, 110, and 120 min after the start of the EU clamp. At the end of the EU clamp, 
different muscle groups were rapidly dissected and frozen at -80° C for analysis. For the 
determination of plasma [3-3H] glucose and 2-deoxy-d-[1-14C]glucose concentrations, 
plasma was deproteinized with ZnSO4 and Ba(OH)2, dried to remove 
3H2O, resuspended in 
water, and counted in scintillation fluid (Ultima Gold; Packard Instrument Co.). For the 
determination of tissue 2-deoxy-d-[1-14C]glucose (2-DG)-6-phosphate (2-DG-6-P) content, 
tissue samples were homogenized, and the supernatants were subjected to an ion-exchange 
column to separate 2-DG-6-P from 2-DG, as described previously. The radioactivity of 3H 
in tissue glycogen was determined by digesting tissue samples in KOH and precipitating 
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glycogen with ethanol as previously described. Muscle glycogen synthesis was calculated 
as muscle [3H] glycogen content divided by the area under the plasma [3H] glucose-
specific activity profile.  
 
3.20 Autophagic flux quantification  
We monitored autophagic flux in fed and 24 h starving mice by using colchicine as 
previously described (Milan et al., 2015). Briefly muscle specific transgenic TFEB mice 
were treated with 0,4 mg/kg colchicine or vehicle by i.p. injection each 12 hours and 
starved. The treatment was repeated two times before muscle harvesting.  
 
3.21 In vivo ChIP Assays 
We performed ChIP assays on TFEB3XFlag overexpressing or WT muscle, by using the 
Chromatin Immunoprecipitation (ChIP) assay kit (Millipore) according to (Milan et al., 
2015). Briefly, muscle were homogenized on ice and integer nuclei were extracted and 
fixed with 1% formaldehyde solution at RT for 10 min. After washing nuclei were 
sonicated to obtain a chromatin size centered in 700bp. Chromatin was divided in aliquots, 
pre-cleared and incubated overnight with the following antibodies. We used anti-FLAG 
antibody (F7425Sigma-Aldrich). Oligonucleotide primers for amplification of a TFEB 
binding site on the GLUT1, GLUT4, nNOS, NRF1, NRF2 and TFAM promoters are listed 
below, together with the position with respect to TSS where CLEAR site is located. 
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3.22 Statistical analysis. 
Data are expressed as mean values ±SE. Results were evaluated by repeated-measures 
ANOVA, multivariate analysis of variance (MANOVA), or Student’s two-tail t test. A p 
value < 0.05 was considered statistically significant. In all figures, *p<0.05, **p<0.01, and 
***p<0.001. 
 
 
3.23 Real-time PCR 
For mtDNA content analysis, SYBR Green real-time PCR was performed using primers 
specific to a mouse mtDNA region in the ND1 gene and primers specific to RNaseP, a 
single copy gene taken as a nuclear gene reference, as described (Viscomi et al., 2009). For 
the analysis of transcripts, total RNA was extracted from liquid nitrogen snap frozen 
muscle by Trizol, according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA, 
USA). Of total RNA, 2 µg was treated with RNase free-DNase and retrotranscribed using 
the ‘‘cDNA cycle’’ kit (QuantiTect Reverse Transcription Kit - QIAGEN). Approximately 
2–5 ng of cDNA was used for real-time PCR assay (SYBR®Green PCR Master Mix 
Applied Biosystem) using primers specific for amplification of several genes. Autophagic, 
Lipid Metabolism and Glucose Metabolism gene-specific primers are listed below. Fold 
change values were calculated using the ΔΔCt method. An unpaired t-test was used to 
calculate statistical significance.  
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4 Results 
 
4.1 Calcineurin is the phosphatase driving TFEB nuclear 
translocation 
 
Previous studies demonstrated that the mTOR-mediated phosphorylation of TFEB in 
serine residue Ser 211 is responsible for its interaction with the 14-3-3 protein, resulting in 
TFEB cytoplasmic localization (Settembre et al., 2012). Conversely, conditions that lead to 
mTOR inhibition, such as starvation, promote TFEB nuclear translocation and 
transcriptional activation of its target genes (Sancak et al., 2010; Zoncu et al., 2011).  
Although the role of the kinases mediating TFEB phosphorylation has been defined, the 
phosphatases involved in its dephosphorylation have remained elusive.  
For this reason(Known that), in the HCS Facility at TIGEM we performed a high-content 
screening of a phosphatase siRNA library in order to identify the enzymes responsible for 
TFEB dephosphorilation.  
The screening was based on a cellular assay in which TFEB cytoplasm-to-nucleus 
shuttling during starvation was monitored. We tested the effects of the specific inhibition 
of each of 231 phosphatases of the library on TFEB subcellular localization in a TFEB-
GFP cell line. If the silenced phosphatase was critical for TFEB shuttling to the nucleus, 
this would result in TFEB cytoplasmic localization during starvation (Figure 1a). 
The most significant hit identified by the primary screening is the calcineurin catalytic 
subunit isoform beta (PPP3CB; Figure 1b); indeed, inhibition of PPP3CB is able to 
suppress starvation-induced TFEB nuclear translocation as shown in Figure 1c. 
For this reason we focused subsequent studies exclusively on this phosphatase. 
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The ability of calcineurin to promote TFEB nuclear translocation was further confirmed 3 
in the HeLaTFEB-GFP cell line by using a set of 3 different PPP3CB siRNAs, as well as the 
pool of 3 ( Figure 2a ). Once more, inhibition of the catalytic subunit of calcineurin results 
in TFEB cytoplasmic localization during starvation. 
In addition, calcineurin inhibitors cyclosporin A and tacrolimus (FK506), both jointly and 
individually, reduced TFEB nuclear translocation during starvation ( Figure 2b).  
Finally, overexpression of ΔCnA, a constitutively active form of the subunit, induced 
TFEB nuclear translocation in normally fed cells, suggesting that calcineurin activity is not 
only necessary but is sufficient to induce TFEB nuclear relocalization (Figure 2c). 
a b 
C 
 
Figure 13 – High Content Screening identifies calcineurin as promoter of TFEB translocation.  a. Assay 
design: HeLa TFEB-GFP cells were reverse transfected with siRNAs against each of 231 phosphatease of a 
human library and tested for TFEB nuclear localization during starvation. If the phosphatase silenced was critical 
for TFEB relocalization, this would result in cytosolic TFEB in absence of nutrients. b.  Statistical analysis of the 
results. The graph scores the significance (log p-value) of the ability of individual siRNAs to inhibit starvation-
mediated TFEB nuclear translocation. The top 5 best-scored siRNAs (p value<0.01), corresponding to 5 different 
phosphatases, are indicated with red dots. The siRNA against PPP3CB, the catalytic subunit of the calcineurin 
gene isoform beta, had the most significant score score. c. Representative images from the HCS using PPP3CB 
siRNA (siPPP3CB). 
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4.2 Calcineurin modulates TFEB subcellular localization 
during exercise 
 
In order to deeper investigate the role of calcineurin in promoting TFEB nuclear 
translocation, we moved in vivo focusing our attention on skeletal muscle, a tissue in 
which calcineurin activity has long been studied. 
C 
b 
a 
 
Figure 14 – Calcineurin regulates TFEB nuclear translocation. a. The left plot represents the 
percentage of nuclear TFEB in starved (STV) cells (3h) silenced with each single PPP3CB 
oligonucleotide or the pool of the 3 oligonucleotides compared with starved control cells 
transfected with scramble (SCRMBL) siRNA oligonucleotides. qRT-PCR analysis of PPP3CB 
mRNA levels confirms the efficacy of siRNA-mediated silencing (right plot). Bar graphs show 
mean ± s.d. for n = 3 independent experiments. b. Pharmacological inhibition of calcineurin 
reduces starvation-mediated TFEB nuclear localization. Images from normally fed or 1 h starved 
HeLaTFEB-GFP cells treated with FK506 (5 µM) and/or CsA (10 µM). Plot represents the percentage 
of nuclear TFEB translocation compared with DMSO-treated fed and starved cells. Bar graphs 
show mean ± s.d. for n = 3 independent experiments. Scale bar, 10 µm. c. HeLaTFEB-GFP cells were 
transfected with a constitutively active form of calcineurin (HA-tagged-1CaN). The plot represents 
the percentage of TFEB nuclear translocation. Data show the mean ± s.d. of n = 3 independent 
experiments. Scale bar, 10µm.  
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Transfection by electroporation of both calcineurin subunit ΔCnA and its essential 
regulatory subunit CnB (PP3CR1) in Tibialis Anterior muscles (TA) of adult wild-type 
mice significantly induced the nuclear translocation of TFEB-GFP reporter (Figure 3), 
confirming that calcineurin activity is sufficient to promote TFEB relocalization also in 
vivo.  
Moreover, a single bout of acute exhaustive exercise, a physiological stimulus that strongly 
activates calcineurin in response to calcium transients during contraction, is able to 
promote TFEB-GFP nuclear translocation in muscle fibers (Figure 3). Nevertheless, this 
effect was almost completely blunted if the endogenous calcineurin inhibitor, CAIN, was 
overexpressed into myofibers ( Figure 3).  
 
 
 
In conclusion, these gain and loss-of-function data demonstrate that calcineurin plays a 
crucial role in the regulation of TFEB subcellular localization in skeletal muscle during an 
energy-demanding condition such as physical exercise. 
 
 
 
 
Figure 15 - Exercise induces TFEB nuclear translocation through calcineurin. Muscles were transfected by 
electroporation with TFEB–GFP (green), ΔCnA, its regulatory subunit (CnB) and the calcineurin inhibitor Myc–
CAIN. Dystrophin antibody (Dys, red) was used to visualize myofibers. The plot shows the percentages of 
TFEB-positive nuclei in muscles under the following conditions: sedentary (control), sedentary with calcineurin 
(ΔCnA +CnB), exercised (run), exercised with CAIN (run + CAIN). The graph represents mean ± s.d. of n = 3 
mice. Scale bar, 50 µm  
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4.3 Generation of muscle specific TFEB overexpressing and 
KO animals 
 
Previous evidences showed that TFEB nuclear shuttling is a phenomenon triggered in 
skeletal muscle by energy demanding conditions, such as physical exercise. 
Skeletal muscle, an important insulin and autophagy-dependent tissue (Grumati & 
Bonaldo, 2012; Mammucari et al., 2007; Masiero et al., 2009), is the principal organ 
involved in contraction; for this reason we started to investigate the role of TFEB in this 
tissue, trying to explain the physiological meaning of TFEB nuclear translocation during 
physical training.  
For this purpose we took advantage of 3 different genetic models in which we could 
activate or down-regulate the expression of our transcription factor specifically in skeletal 
muscle.  
Overexpression of Tcfeb, the murine homologue of human TFEB, was achieved in skeletal 
muscle by means of viral mediated gene transfer using the Adeno Associated Virus (AAV) 
system. Adult mice were injected intramuscularly (TA or GNM muscles) with either 
AAV2.1-CMV-TFEB or AAV2.1-CMV-GFP control vector; mice were sacrificed after 21 
days, time required for an efficient TFEB expression (Figure 4a).  
In addition, we generated a tamoxifen inducible muscle-specific TFEB transgenic mouse 
line; this was possible by crossing a line in which Tcfeb3XFlag cDNA was inserted after a 
CAGCAT cassette and another line expressing Cre-ER under the control of human skeletal 
actin (HSA) promoter (McCarthy et al., 2012). 3 days of intraperitoneal (IP) tamoxifen 
treatment in both Cre-positive and Cre-negative adult mice were sufficient to activate Cre-
LoxP recombination and the overexpression of TFEB only in skeletal muscle (Figure 4b), 
recapitulating the induction obtained with AAV2.1-TFEB delivery. 
Results 
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For the loss of function approach, we generated a conditional muscle-specific TFEB-KO 
mouse line by crossing Tcfeb floxed (Settembre et al., 2013) with MLC1f-Cre transgenic 
mice (Bothe et al., 2000). Efficiency and specificity of the gene deletion were confirmed 
by quantitative real time-PCR (qRT-PCR) analysis on multiple tissues (Figure 4c).  
 
4.4 Genome-wide analyses identified glucose-related and 
mitochondrial genes as downstream targets of TFEB 
 
We started our study performing a transcriptomic analysis in skeletal muscles from both 
TFEB overexpressing and TFEB knock-out (KO) mice by means of whole-genome gene 
expression profiling experiments (SuperSeries-GSE62980).  
In infected muscles, overexpression of TFEB results in the up-regulation of 1514 genes 
and the down-regulation of 1109 genes (GSE62975), while genetic ablation of the 
transcription factor increases 496 genes and suppresses 458 genes (GSE62976). 
In order to identify the main cellular compartments (CCs) and the principal biological 
processes (BPs) related to TFEB-dependent genes, we next carried out a Gene Ontology 
Enrichment Analysis (GOEA). The GOEA was made on the lists of genes whose 
expression was either increased or decreased in transfected or knock-out muscles. 
Interestingly, several gene categories related to cellular metabolism, including lipid and 
a b c 
Figure 16 – Expression analysis of TFEB transcript. a. The TFEB transcript from AAV2.1-TFEB transfected 
muscle was quantified by qRT-PCR as well as from transgenic animals (b). Expression levels of endogenous 
Tcfeb mRNA in different tissues isolated from TFEB-KO and WT mice. Bar represent mean ± SE for n = 5; 
**p<0.01,***p<0.001.  
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glucose homeostasis, are up-regulated in TFEB overexpressing muscle and down-regulated 
in TFEB-KO (Figure 5). Strikingly, genes involved in mitochondrial biogenesis are 
oppositely regulated by gain and loss of function approaches. Indeed 38 genes involved in 
mitochondrial function are induced in AAV2.1-TFEB infected muscles, while 73 genes are 
inhibited in TFEB-KO muscles. 
 
4.5 TFEB regulates mitochondrial biogenesis in skeletal muscle 
 
Based on these gene expression evidences, we started to dissect the potential effects of 
TFEB on mitochondrial function analyzing mitochondrial morphology in muscles 
overexpressing or lacking TFEB. Electron microscopy (EM) analyses show a remarkable 
increase in mitochondrial density and volume in TFEB-overexpressing muscles, both from 
infected and transgenic animals (Figure 6b, 6d, 6e, 6f). Interestingly, mitochondrial density 
and size are normal in the TFEB-KO muscles, even if there is an increased number of 
damaged organelles (Figure 6c, 6e, 6f, 6h). Consistent with these EM data, infected 
Figure 17 - TFEB gene network. Genes affected by TFEB expression are shown in colored circles. Red 
circles represent genes upregulated in TFEB-AAV overexpression; genes downregulated in KO animals are 
shown as green circles. Genes are divided in functional sub-categories; genes related to lipid and carbohydrate 
metabolism are strongly induced upon TFEB overexpression and blocked by TFEB deletion. 
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muscles also display an increase in mitochondrial DNA content (mtDNA), while no 
differences are observed in the knock-out counterpart (Figure 6g).  
 
Through qRT-PCR analysis we revealed that TFEB overexpression in muscle induces the 
expression of many genes involved in mitochondrial biogenesis and function (Figure 7a), 
including the master gene of mitochondrial biogenesis PGC1α, already known to be direct 
target of TFEB (Settembre et al., 2013). Moreover, another PGC-1 family member, 
PGC1β, was also  up-regulated by TFEB overexpression. Consistently with these gene 
expression data, we found a significant induction of peroxisome proliferator activated 
receptor α (PPARα), PPARβ/δ and PPARγ in TFEB-overexpressing muscles. 
Nevertheless, TFEB deletion is not affecting the expression of PGC1α/β and PPAR genes 
with the exception of PPARα that is down-regulated. 
For this reason, in order to elucidate the possible mechanisms underlying the induction of 
mitochondrial biogenesis gene program in TFEB transfected muscles, we examined the 
TFEB-TG a b c d 
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Figure 18 - TFEB induces mithocondrial biogenesis. a-d. Electron microscopy analysis of skeletal muscles 
from WT mice transfected with AAV2.1-GFP (a), AAV2.1-TFEB (b), TFEB-KO (c) and TFEB-TG mice (d). 
Normal mitochondria are indicated by black arrows (a, b), while abnormal mitochondria in TFEB-KO muscle 
are pointed by empty arrows (c). Increased mitochondrial size can be easily appreciated in TFEB-TG muscles 
(d). Scale bar represents 500 nm. e-f. Morphometrical analyses of mitochondria in TFEB overexpressing, TFEB- 
KO and control muscles. Bars represent mean±SE, n=3; **p<0.01. g. mtDNA copy number detection in muscles 
infected with AAV2.1-TFEB and from TFEB-KO and control mice. Data are shown as mean±SE, n=3; 
**p<0.01. h. Quantification of abnormal mitochondria in TFEB-KO gastrocnemius (GNM) muscles versus 
controls. Data are expressed as percentage of abnormal mitochondria on total mitochondria of 16. Bars represent 
mean±SE; *p<0.05. 
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expression of nuclear respiratory factors 1 and 2 (NRF1and NRF2), two well-known 
candidates regulating nuclear expression of mitochondrial genes (Scarpulla, 2006). The 
mRNA level of NRF2 is increased, as well as that of NRF downstream genes including 
mitochondrial transcription factor A (TFAM). In vivo chromatin immune-precipitation 
experiments confirm the direct recruitment of TFEB on NRF2 and NRF1 promoter (Figure 
7c) but not on TFAM one (data no show), suggesting a possible mechanism TFEB-
dependent and PGC1α/β-independent regulating mitochondrial biogenesis. 
Finally, overexpression of TFEB in skeletal muscle increased the expression of different 
mitochondrial enzymes. Indeed, subunits of the four respiratory chain complexes and the 
ATP synthase, as well as genes encoding electron transport and TCAproteins were induced 
by TFEB overexpression and were reduced by TFEB deletion (Figure 7b).  
 
 
 
a b c 
Figure 19 - TFEB regulates mitochondrial biogenesis and function gene expression. a. mRNA levels of 
genes related to mitochondrial biogenesis and b. mitochondrial function in WT (blue bar), infected (red bar) and 
TFEB-KO (green bar) muscles. Data were normalized for GAPDH and expressed as fold induction relative to the 
WT. Bars represent mean±SE, n=3; *p<0.05, **p<0.01. c. Chromatin immunoprecipitation analysis in muscles 
from TFEB transgenic and WT mice. CLEAR elements in NRF1 and NRF2 promoters are depicted as red boxes. 
TSS (Transcriptional Start Site) indicates the starting point of the first exon. The histograms show the amount of 
immunoprecipitated DNA as detected by qRT-PCR normalized to input. Bars represent mean±SE of three 
independent experiments; *p<0.05, **p<0.01, ***p<0.001. 
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4.6 TFEB regulates mitochondrial function and energy 
production in skeletal muscle 
 
Data showed before clearly demonstrate a TFEB-dependent gene expression program for 
mitochondrial biogenesis and respiratory chain genes. For this reason, to better 
characterize the involvement of TFEB in mitochondrial respiration, in collaboration with 
the group of prof. Zeviani we analyzed the specific activities of enzymes involved in 
oxidative phosphorylation. Biochemical analysis of muscle samples infected with both 
AAV2.1-TFEB or control vector show an increase in the activities of citrate synthase, 
mitochondrial respiratory chain complex I (CI), CII, CIII and CIV (Figure 8a). Conversely, 
TFEB deletion lead to a slight decrease only in CII activity, the complex containing the 
SDHA flavoprotein, keeping unaltered all the other respiratory chain complexes activities 
(Figure 8a).  
To further corroborate the role of TFEB in mitochondrial function we also took advantage 
of the inducible muscle-specific transgenic mouse line. Acute activation of TFEB by 
tamoxifen treatment in adult mice recapitulates the phenotype of AAV2.1-TFEB 
overexpression on mitochondria biogenesis and complex II activity, as shown by SDH 
staining in Figure 8b. Consistent with these data, even mitochondrial respiration is 
significantly enhanced in TFEB over-expressing muscles (Figure 8c). 
 
 
a 
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Based on these findings, we decided to assess whether these TFEB-mediated changes in 
mitochondrial morphology and function had any impact on energy production. Therefore 
we measured ATP levels that are higher in TFEB transfected muscles and lower in TFEB 
deficient muscles compared to controls (Figure 9a). For this reason, to understand the 
mechanisms underlying this significant decrease in ATP production in TFEB-KO muscles 
we checked mitochondrial function in these animals. To do that, we exploited TMRM, a 
fluorescent dye able to monitor mitochondrial membrane potential (Δψm), the critical 
parameter driving ATP production.  
Therefore, we checked Δψm in isolated adult fibers from WT and TFEB-KO muscles. As 
expected in control mice, oligomycin-dependent inhibition of ATP synthase does not alter 
Δψm over time (Figure 9b) and mitochondrial depolarization is achieved only after 
membrane permeabilization with the protonophore carbonylcyanide-p-trifluoromethoxy 
phenylhydrazone (FCCP). Conversely, mitochondria of TFEB-null fibers undergo a 
significant depolarization after oligomycin treatment (Figure 9b), suggesting that these 
fibers are at least in part relying on reverse activity of ATP synthase to preserve their 
membrane potential. Thus, these findings elucidate that the lower ATP production in 
knock-out muscles is due to a  mitochondrial membrane proton leak. 
 
 
Figure 20 – TFEB regulates mitochondrial complex activity and respiration. a. Mitochondrial respiratory chain 
activity in muscles of WT, AAV2.1-TFEB infected and TFEB-KO mice. Data are expressed as percentage of specific 
activity respect to the WT. Data are expressed as mean ±SE, n=4; *p<0.05, **p<0.01. b. SDH staining of sections 
from TFEB transgenic and WT mice. Scale bar represents 100 µm. c. Mitochondrial respiration measurements in 
muscles from TFEB transgenic and control mice. TFEB induction significantly increases oxygen consumption rate 
when glutamate/malate are used as substrates. Data are presented as mean ± SE; n=3; **p < 0.01. 
a b 
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4.7 TFEB regulates mitochondrial biogenesis in skeletal muscle 
through a PGC1α-independent mechanism 
 
Both PGC1α and PGC1β are master regulators of mitochondrial biogenesis and oxidative 
metabolism. Anyway, recent evidences suggest the presence of an independent pathway 
able to regulate mitochondrial biogenesis during exercise (Rowe, El-Khoury, Patten, 
Rustin, & Arany, 2012). Therefore, we tried to define whether TFEB is the missing sensor 
of physical activity that coordinates metabolic responses independently from PGC1α. To 
do that, we first checked the expression and localization of endogenous TFEB in PGC1α 
knockout (PGC1α-KO) mice before and after exercise. TFEB was expressed at lower 
levels and it was more cytosolic in PGC1α-KO mice when compared to controls (Figure 
10a). Importantly, exercise restored a normal TFEB expression (Figure 10a), induced 
TFEB nuclear translocation (Figure 10b) and triggered up-regulation of genes related to 
mitochondrial biogenesis (data not shown).  
 
 
Figure 21 – TFEB regulates ATP production and mitochondrial membrane potential. a. ATP 
production per gr of tissue from TFEB infected and TFEB-KO mice respect to controls. Data are 
shown as means ± SE (n=5); **p<0.01, ***p<0.001. b. Mitochondrial membrane potential 
measurements in myofibers from FDB WT and KO muscles. Where indicated, 6 µM oligomycin or 4 
µM FCCP were added. Each trace represents TMRM fluorescence of a single fiber. The fraction of 
myofibers with depolarizing mitochondria is indicated for each condition.  
a b 
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Electron microscopy analysis of PGC1α-KO muscles infected with AAV2.1-CMV-TFEB 
reveals an increase in mitochondrial volume and density (Figure 11a) that correlates with 
an augmented activity of CI, II, III and IV (Figure 11c). Moreover, the levels 
mitochondrial biogenesis regulator such as TFAM, NRF1 and NRF2 are significantly up-
regulated by TFEB over-expression even in the absence of PGC1α (Figure 11b).  
Altogether, these findings strongly suggest that the induction of mitochondrial biogenesis 
in TFEB overexpressing muscles does not depend on the presence of PGC1α.  
 
 
Figure 23 – TFEB controls mitochondrial biogenesis and function independently from PGC1α. a. EM images of 
PGC1α-/- muscles infected with AAV2.1-TFEB or AAV2.1-GFP. The electron micrographs reveal an accumulation 
of mitochondria in TFEB-overexpressing muscle and a granular staining consistent with glycogen particles. The scale 
bars represent 500 nm. c. The mitochondrial respiratory chain activity in WT and PGC1α-/- muscle infected with 
control or TFEB vector. Data are expressed as percentage respect to the WT muscles infected with control vector. 
Bars represent mean ± SE for n=3; *p<0.05.  
 
a b 
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Figure 22 - Exercise induces TFEB expression and nuclear localization in PGC1α -/- 
muscle. a. TFEB mRNA levels in PGC1α-/- muscles infected with AAV2.1 control or 
AAV2.1-TFEB. Data are compared with TFEB expression in WT mice. Measurements 
were performed in sedentary and runner animals. Bars represent mean±SE for n=3; 
*p<0.05, ***p<0.001. b. Immunohistochemical analysis of TFEB in PGC1α-/- muscles 
from sedentary and exercised mice. Control means endogenous TFEB in muscles 
infected with AAV2.1 control virus. TFEB means total amounts of TFEB in muscles 
infected with AAV2.1-TFEB. Arrows indicate exercise-induced TFEB nuclear 
localization. The scale bars represent 50 µm 
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4.8 TFEB controls energy balance in skeletal muscle during 
exercise 
 
It is well established that physical activity has a major impact on glucose homeostasis and 
mitochondrial biogenesis and function (Cartee et al., 2016). For this reason, we wondered 
whether acute exhausting versus mild and chronic exercise trainings are equally able to 
activate TFEB. As readout of TFEB activation we monitored its nuclear localization. We 
previously proved that acute exhausting contractions lead to TFEB nuclear translocation 
(Figure 3) even if mild exercise is not able to promote this massive subcellular 
relocalization (Figure 12a). Anyway, 7 weeks of training with progressive increase of 
intensity without reaching exhaustion are inducing a massive TFEB nuclear translocation 
with concomitant cytosolic depletion comparable to the effect of one acute exhausting bout 
(Figure 11a). Therefore, intensity and duration of training are critical factors that affect 
TFEB nuclear translocation and its ability to promote transcription of genes related to 
mitochondrial biogenesis and function (Figure 12b).  
 
 
 
  
b 
b  a
Figure 24 - TFEB nuclear translocation is induced depending on exercise intensity. a. Endogenous TFEB was 
immunostained in muscles of sedentary, 4 days mild exercised and 7 weeks intense trained WT mice. Arrows 
indicate TFEB nuclear localization, which is related to exercise intensity. b. Expression analysis of genes related to 
mitochondrial biogenesis and mitochondrial respiratory chain in WT skeletal muscle before and after acute 
exhastive exercise. Data are shown as mean ±SE, n=3; *p<0.05, **p<0.01. 
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At this point, to unravel the physiological consequences of TFEB translocation during 
physical activity we decided to examin exercise performance in both TFEB-KO and 
inducible muscle-specific TFEB transgenic mice. During high intensity training, TFEB-KO 
mice appear to be significantly exercise-intolerant compared to controls (Figure 13a) while 
the acute activation of TFEB in skeletal muscle enhances physical performances, 
consistently with the measured increased mitochondrial respiration.  
To better understand the exercise intolerance of the TFEB-KO mice, in collaboration with 
prof. Pessin laboratory in New York, we performed calorimetric recordings during 
treadmill running. While WT mice maintain a constant level of energy expenditure during 
physical activity, the knock-out mice display a drop after 15 minutes of physical exercise 
(Figure 13b). Moreover, metabolic analyses reveal that in basal condition TFEB-KO mice 
have a higher respiratory exchange rate (RER) than controls (Figure 13c) suggesting that 
TFEB-KO mice depend more on glucose oxidation with respect to controls. In addition, 
while WT mice maintain a relatively constant RER during the running period, TFEB-KO 
mice show a drop of RER after 20 min (Figure 13c), indicating a shift in substrate usage 
from glucose to fatty acid metabolism.  
Finally, we measured glucose and fatty acids levels in muscle and blood from TFEB-KO 
and TFEB transgenic mice before and after exercise. TFEB-KO mice show lower blood 
glucose levels compared to WT mice in basal condition (Figure 13d). However, exercise 
causes a 50% reduction of blood glucose in TFEB-KO, transgenic and control mice 
(Figure 13d). Insulin levels mirrored the changes of blood glucose, as they were reduced in 
basal condition in TFEB-KO mice and dropped after exercise in the different genotypes 
(Figure 13e).  
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At this point we had enough evidences showing that TFEB-KO mice are hypoglycemic, 
contain dysfunctional mitochondria and produce less ATP.  
Thus, we reasoned whether they use the anaerobic glycolysis to produce energy. 
Consistent with this hypothesis, we found higher levels of lactate in blood of TFEB-KO 
mice before and after exercise compared to controls (Figure 14a). On the contrary, lactate 
of transgenic mice is already lower than controls in resting condition and is not increasing 
after exercise, indicating that TFEB transgenic mice better oxidize glucose for energy 
production.  
To further confirm these findings we measured glycogen content in skeletal muscle. In 
basal conditions, glycogen levels are remarkably lower in TFEB-KO mice and higher in 
transgenic TFEB muscles compared to WT. Enzymatic quantification shows that glycogen 
content is 3 fold less after TFEB ablation and 10-fold higher after TFEB overexpression 
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Figure 25 - TFEB controls energy balance in skeletal muscle. a. To determine exercise 
capacity mice were run on a treadmill; during high-intensity exercise, transgenic mice ran more 
than WT mice while KO animals displayed a marked exercise intolerance. Data are shown as 
mean±SE, n=10; **p<0.01. b. Energy expenditure and c. RER were determined during exercise 
in TFEB-KO and WT mice. The figure shows the mean RER measured at peak oxygen 
consumption, n=8. d-e. Serum metabolites quantification before and after high intensity 
exercise in WT, TFEB transgenic and TFEB-KO mice. Data are shown as mean +/-SE, n=8; 
*p<0.05, **p<0.01, ***p<0.001. 
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compared to controls (Figure 14b). Periodic Acid Schiff (PAS) staining (Figure 14c) 
confirms this glycogen accumulation in transgenic animals. 
Anyway, exercise leads to glycogen consumption in transgenic, TFEB-KO and control 
muscles (Figure 14b) even if the lower glycogen content detected in sedentary TFEB-KO 
muscles explains the drop of RER observed after a 15 min exercise. Since glycogen is 
rapidly consumed in TFEB-KO mice, the additional need for energy during exhausting 
exercise requires a switch from glycolysis to fatty acid oxidation as detected in RER 
recordings. Thus, while blood free fatty acids (FFAs) concentrations are reduced after 
exercise in both TFEB-KO mice and controls (Figure 14d), their muscle content 
dramatically drops after exercise only in TFEB-KO mice (Figure 14e). 
Altogether these finding indicate that TFEB is supporting metabolic flexibility of skeletal 
muscle during exercise, highlighting a new role for this transcription factor always referred 
as a master regulator of autophagy. 
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Figure 26 - Blood and muscle metabolites before and after high intensity exercise.  a. Lactate quantification  
after exhaustive contraction in WT, TFEB transgenic and TFEB-KO mice. Data are shown as mean +/-SE, n=8; 
*p<0.05, **p<0.01, ***p<0.001. b. Enzymatic quantification of muscle glycogen before and after high intensity 
exercise in WT, TFEB transgenic and TFEB-KO mice. Data are shown as mean ±SE, n=8; **p<0.01. c. Periodic 
acid Schiff (PAS) staining of cryosections from TFEB transgenic and WT mice. d-e. Quantitative analysis of serum 
and muscle FFA before and after high intensity exercise in TFEB-KO and WT mice. Data are shown as mean +/-SE, 
n=8; *p<0.05, **p<0.01. 
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4.9 TFEB controls metabolic flexibility and energy balance 
independently of autophagy and proteostasis 
 
Different evidences agree with the role of exercise as a potent activator in skeletal muscle 
of autophagy (Grumati, Coletto, Sandri, et al., 2011; He et al., 2012) and ubiquitin-
proteasome systems (Cunha et al., 2012). In particular, in our and other laboratories it has 
been proved that autophagy is not required to sustain physical exercise, but is fundamental 
for clearance of dysfunctional mitochondria during and after training (Lo Verso et al., 
2014). For this reason, we checked whether TFEB, known to be a master regulator of 
autophagy (Settembre et al., 2011) and from now on also an exercise-activated regulator of 
muscular metabolic flexibility, is mediating this new function in adult skeletal muscle 
through the control of this catabolic mechanism. Surprisingly, TFEB activation was not 
sufficient to enhance autophagy flux in presence or absence of nutrients (Figure 15a). 
Moreover, activation of TFEB did not induce protein breakdown and muscle loss. Indeed, 
most of the atrophy-related genes belonging to the ubiquitin- proteasome and autophagy-
lysosome systems are not induced by TFEB over-expression (Figure 15b). Similarly, also 
mitophagy genes are not affected. However, when we measured cross-sectional area of 
transgenic muscles, we found a shift towards smaller size suggesting that also protein 
synthesis is not induced (Figure 15c). Thus, this decrease in fiber size is merely due to a 
metabolic shift and the reason for this phenomenon relies on the fact that oxidative fibers 
are smaller than glycolytic skeletal muscle fibers (Schiaffino & Reggiani, 2011). 
Furthermore, we did not find any significant difference in myosin distribution between 
transgenic and control muscles (Figure 15d). Therefore, TFEB controls myofibers 
metabolism but not myosin content/type independently from autophagy or proteostasis. 
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4.10  TFEB controls glucose homeostasis and insulin sensitivity 
independently of PGC1α 
 
We previously demonstrated that TFEB-KO muscles contain lower glycogen levels than 
controls; therefore, we reasoned that this feature could probably depend on an abnormal 
regulation of glucose homeostasis. Thus, always in collaboration with Pessin’s lab, we 
performed euglycemic-hyperinsulinic (EU)-clamps observing that the glucose infusion rate 
(GIR) required to maintain a constant glycemia during insulin treatment is significantly 
reduced in TFEB-KO mice compared to control (Figure 16a). This reduction is consequent 
to a decrease in skeletal muscle glucose uptake (Figure 16b), which causes as consequence 
a decrease of glycogen synthesis (Figure 16c). Altogether these data demonstrate that 
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Figure 27 - TFEB controls metabolic flexibility independently from autophagy and protein breakdown. a. 
Left panel: representative blots of p62 and LC3 from muscle lysates of WT and TFEB transgenic animals in fed 
conditions. Mice were treated with colchicine (Colch.) or vehicle for autophagy flux measurements. Lower panel: 
immunoblot analysis of LC3 from muscle lysate from fed or 24 h fasted TFEB tg or control mice. GAPDH was 
used as loading control. b. Quantitative RT-PCR atrophy-related ubiquitin ligases (MusA1, Atrogin1, MuRF1, 
Fbxo31, Fbxo21 and Itch) c. gene expression measurements of autophagy/mitophagy genes (p62/SQSTM1, LC3, 
Pink, Parkin, Bnip3 and Gabarapl). Data are normalized to GAPDH and expressed as fold increase compared to 
control animals. n=4 muscles in each group Values are mean ± SE *p<0.05, ***p<0.001, ****p<0.0001. d. 
Frequency histograms showing the distribution of myofibers cross-sectional areas (µm2) from transgenic muscles. 
Values are shown as means ± SE *p<0.05, from 4 muscles in each group. e. Percentage of type I and different type 
II fibers in WT and TFEB tg muscles. Values are shown as means ± SE *p<0.05, from 4 muscles in each group.  
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TFEB deficiency in skeletal muscle results in peripheral insulin resistance, reduced 
glucose uptake and decreased glycogen content. 
 
 
These findings are mirroring the transcriptomic signature of TFEB-overexpressing and 
TFEB-KO muscles. Thus, to further confirm these evidences, we monitored the expression 
levels of glucose homeostasis-related genes in both muscles injected with AAV-TFEB and 
from transgenic mice; we found a significant increase in the expression of GLUT1 and 
GLUT4, the GTPase involved in GLUT4 translocation (TBC1D1) and the rate limiting 
enzymes of glycolysis (Hexokinase 1 and 2) (Figure 17a). The induction of genes involved 
in glucose uptake is also coupled with an increase of transcript and protein of GYS (Figure 
17b, 17c), explaining the accumulation of glycogen in transgenic muscles. GYS activity is 
negatively regulated by phosphorylation of the C-terminal region by glycogen synthase 
kinases (GSK3s) (Jensen & Lai, 2009); anyway, the phospho-GYS levels are unchanged in 
AAV-TFEB muscles and, therefore, the pGYS/GYS ratio is dramatically decreased in 
TFEB-overexpressing muscles when compared to controls (Figure 17c).  
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Figure 28 - TFEB ablation results in a decreased rate of insulin-stimulated glucose uptake. a. EU 
clamps were used to assess whole body insulin sensitivity by determining the glucose infusion rate required 
to maintain euglycemia in WT and TFEB-KO mice. Data represent the means ±SE from 5-6 individual mice 
per group; *p<0.05. b. TFEB deletion results in a reduction of insulin-stimulated glucose uptake in muscle. 
Glucose uptake into muscle tissues was determined by 2-deoxy-d-[1-14C]glucose injection during the last 35 
min of insulin infusion during the EU clamp. These data represent the means ±SE of 5-6 mice per group; 
*p<0.05. c. The amount of glucose conversion to glycogen in muscles from WT and TFEB-KO mice was 
determined during the EU clamp by infusion of [3-3H]glucose. Data represent the means ± SE from 5-6 
mice per group; *p<0.05. 
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Moreover, expression analysis of genes related to glucose metabolism does not reveal any 
significant difference between PGC1α-KO and controls after viral TFEB overexpression 
(Figure 18). Altogether these data strongly indicate that TFEB is able to control also 
muscle glucose uptake and glycogen synthesis in a PGC1α-independent manner. 
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Figure 29 - TFEB controls genes related to glucose metabolism. a. qRT-PCR of glucose 
uptake and glycogen biosynthesis related genes in muscles both infected with AAV2.1-TFEB 
and form TFEB transgenic animals. Data were normalized for GAPDH and expressed as fold 
induction relative to WT. Data are shown as mean±SE, n=3; *p<0.05, **p<0.01. b. mRNA 
levels of glycogen synthase and c. western blot analysis of total and phosphorylated GYS from 
muscle extracts. Representative blot images are shown (left panel). Densitometric quantification 
is depicted on the right panel. Data are shown as mean±SE, n=3; *p<0.05. 
Figure 30 - TFEB regulates glycogen synthesis independently of PGC1α . qRT-PCR analysis of genes 
related to glucose uptake and glycogen biosynthesis in PGC1α-/- and WT mice infected with AAV2.1-
GFP or AAV2.1-TFEB. Data are shown as mean±SE, n=3; *p<0.05, **p<0.01. 
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4.11 Glucose-related signaling pathways are affected by TFEB 
 
GLUT transporters activity is known to be tightly controlled form several pathways. For 
this reason, we checked whether TFEB impinges not only on GLUT1-4 expression but also 
on glucose-related signaling. Previous studies showed that Nitric Oxide (NO) controls 
several metabolic aspects of skeletal muscle including mitochondrial biogenesis and 
glucose uptake (De Palma et al., 2014; Stamler & Meissner, 2001).  NO is formed by nitric 
oxide synthase (NOS), via the conversion of L-arginine to L-citrulline. Skeletal muscle 
express neuronal (nNOS), endothelial (eNOS) and inducibile (iNOS) isoforms (Andrew & 
Mayer, 1999); however, nNOS is the major isoform involved in AMPK-dependent 
regulation of GLUT4 (Lira et al., 2007). We found that the nNOS transcription and protein 
expression are increased in TFEB-over expressing muscle and decreased in muscle from 
TFEB-KO mice (Figure 19a, 19b).  
To test whether nNOS and glucose transporter genes are direct target of TFEB we further 
analyzed their promoters and identified CLEAR sites. Chromatin immunoprecipitation 
experiments showed that TFEB is recruited on nNOS, GLUT1 and GLUT4 promoters 
(Figure 19c), thus directly controlling their expression. 
Moreover, since AMPK is a downstream target of nNOS (Lira et al., 2010), we also 
monitored its activation. TFEB overexpression in muscle shows a significant induction of 
AMPK phosphorylation and of its downstream target Acetyl-CoA carboxylase (ACC) even 
if no changes are found in TFEB-KO muscles (Figure 19d). 
To conclude, all these findings highlight the role of TFEB in controlling not only glucose 
related genes expression, but also a part of the signaling pathways involved in glucose 
homeostasis. 
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Figure 31 - TFEB controls glucose uptake via regulation of AMPK signaling 
pathways. a. qRT-PCR analysis of nNOS transcript in WT, TFEB-infected and 
TFEB-KO muscles. Value are expressed as fold induction compared to controls. 
Data are shown as mean±SE, n=8; *p<0.05, **p<0.01 b. Western Blot detection of 
nNOS and densitometric quantification. Values are normalized for GAPDH 
(*p<0.05; ***p<0.001). c. ChIP analyses in muscles from TFEB transgenic and 
WT mice on nNOS, GLUT1 and GLUT4 promoters. The histograms show the 
amount of immunoprecipitated DNA as detected by qRT-PCR normalized to input. 
Bars represent mean±SE of three independent experiments; *p<0.05, **p<0.01, 
***p<0.001. d. Western blot analysis of AMPK, pAMPK and pACC on protein 
extracts from muscles infected with AAV2.1-TFEB, TFEB-KO or WT mice. 
Representative images (left) and densitometric quantification (right) are shown 
(*p<0.05). 
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5 Discussion 
 
The beneficial effects of physical activity on mitochondrial content/function, fatty acid 
oxidation and glucose homeostasis are well known (Hawley, 2002; Holloszy & Coyle, 
1984; Holloszy, Kohrt, & Hansen, 1998). All these features appear to be critical factors 
altered in a vast series of metabolic disorders. Moreover, dysfunctional mitochondria and 
insulin resistance are alarming indexes that negatively influence the process of skeletal 
muscle aging (Egan & Zierath, 2013). Indeed muscle activity is important to counteract 
disease progression in diabetes, obesity and metabolic syndrome and physical training 
together with dietary intervention have been reported to actively counteract ageing 
sarcopenia (Borst, 2004).  
 
Calcium signalling is greatly affected by exercise and the calcium-dependent phosphatase 
calcineurin is one of the most important players for muscle adaptation to physical activity. 
We recently reported that exercise triggers TFEB nuclear localization in a calcineurin-
dependent fashion(Medina et al., 2015) (Medina et al., 2015). Calcineurin 
dephosphorylates TFEB serine residues that play a critical role in determining TFEB 
subcellular localization and promotes its nuclear translocation (Medina et al., 2015). 
Importantly, calcium-dependent signaling also modulates exercise-dependent glucose-
related pathways. Indeed, muscle-specific transgenic mice that overexpress an activated 
form of calcineurin show increased glycogen accumulation and lipid oxidation (Long, 
Glund, Garcia-Roves, & Zierath, 2007); moreover they are characterized by up-regulation 
of PGC1α, several glycolytic enzymes, mitochondrial genes, genes related to lipid 
metabolism and GLUT4 (Long & Zierath, 2008). Conversely, muscle-specific calcineurin 
KO mice show exercise intolerance when subjected to exhausting physical activity 
(Pfluger et al., 2015). Finally, immunosuppression therapy by high-dose treatment with 
calcineurin inhibitors cylosporin A or tacrolimus (FK-506) has been associated with higher 
risk for developing obesity and diabetes in patients (MI, Rego, & Lima, 2003). Altogether 
these data suggest that calcineurin plays a major role in glucose and lipid metabolism even 
if the mechanistic insights these beneficial effects of calcineurin were unknown. Our data 
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suggest that TFEB is a critical calcineurin downstream target that coordinates metabolic 
adaptations such as glucose uptake and mitochondrial function in order to optimize energy 
production to sustain muscle contraction. 
 
In this work we found that TFEB is a major regulator of glucose homeostasis and 
mitochondrial biogenesis providing energetic support to maintain muscle contraction.  
Our in vivo data show that the absence of TFEB causes accumulation of morphologically 
abnormal and dysfunctional mitochondria that display impairment in respiratory chain 
complex II activity and proton leakage leading to a defect in ATP production and exercise 
intolerance. Conversely, over expression of TFEB induces mitochondrial biogenesis, 
improves respiratory chain complex activities and increases ATP production. These 
findings are surprising since the documented effects of TFEB are mainly related to 
lysosomal biogenesis and autophagy regulation.  
The positive effects of TFEB on the mitochondrial network in skeletal muscle appear to be 
independent from the transcriptional co-regulator PGC1α. We found that TFEB is 
sufficient to directly bind and induce the expression of NRF2 and Tfam, two major master 
regulators of mitochondrial biogenesis in muscle, even in the absence of PGC1α; moreover 
TFEB is both sufficient and required for PPARa expression. Therefore, TFEB acts 
independently from PGC1α to promote oxidation of glucose and lipids, which are critical 
substrates during the early and late phase of strenuous contraction (Egan & Zierath, 2013). 
Therefore, TFEB is at least one missing factor that explains why PGC1α is dispensable for 
exercise and mitochondrial biogenesis (Rowe et al., 2012) and not required for exercise-
induced adaptations. Moreover, TFEB directly controls glucose homeostasis via GLUT1/4 
expression and insulin sensitivity via nNOS. Indeed, muscle from TFEB-KO mice showed 
a decreased glucose uptake during (EU)-clamps and near complete absent glycogen stores 
under resting conditions. The insulin resistance of the TFEB deficient fibers prevents 
glucose oxidation and therefore drives the exercising muscle to use fatty acid oxidation 
(FAO) that consequently blocked Pyruvate Dehydrogenase (PDH) enzyme resulting in 
lactate accumulation.  
Altogether these findings strongly suggest that TFEB is a critical player of metabolic 
flexibility during physical activity. 
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In a previous study TFEB was reported to regulate lipid metabolism in liver in a way that 
is mediated, at least in part, by PGC1α (Settembre et al., 2013). Conversely, our findings in 
muscle show that TFEB is directly involved in mitochondrial function and glucose 
homeostasis independently from PGC1α. Thus, these observations indicate that the 
networks of genes regulated by TFEB are context-specific as the gene expression profiles 
have significant tissue-specific changes, supporting distinct tissue-specific metabolic 
functions.  
Nevertheless, TFEB not only regulates expression of glucose transporters and critical 
glycolytic enzymes but also factors that impinge on AMPK regulation such as neuronal 
nitric oxide synthase (nNOS). It was shown that nNOS controls GLUT4 expression in 
skeletal muscle cells through AMPK activation and endogenous nNOS is required for the 
up-regulation of AMPK activity by the AMP mimetic, AICAR (Higaki, Hirshman, Fujii, & 
Goodyear, 2001; Lira et al., 2010; McConell et al., 2010).  
In summary, our results position TFEB as a central coordinator of insulin sensitivity, 
glucose homeostasis, lipid oxidation and mitochondrial function, further emphasizing the 
importance of this regulatory pathway in the metabolic response to energy demanding 
conditions such as physical exercise.  
Thus the unknown master regulator able to coordinate at the same time fuel disposal and 
fuel utilization has been found. 
 
These advances in understanding the transcriptional regulation of exercise-induced muscle 
adaptation obviously open new interesting perspectives for fighting metabolic diseases and 
age related muscle problems. A factor that modulates coordinately mitochondria 
functionality and blood glucose clearance in a insulin-independent manner is for sure a 
potential therapeutic target. It would be visionary thinking of substituting physical exercise 
with a pill; indeed the huge amount of pleiotropic effects cannot be modulated with a 
pharmacological intervention. However, the possible development of drugs mimicking 
TFEB action in skeletal muscle would be for sure a potential intervention to potentiate the 
effects of moderate exercise that also obese and old people can undergo. 
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Of course TFEB activation should be carefully modulated, and further studies in 
understanding the duration of TFEB effects and the kinetic of TFEB mediated adaptation 
to physical exercise should be addressed in advance.  
In conclusion, these findings spread for sure new possibilities and farsighted perspectives 
in the fight of metabolic syndromes and aging. 
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